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ABSTRACT
MOLECULAR MODELING STUDIES OF ACETYLCHOLINESTERASE
by
Charilaos E. Linaras
The controversial role of electrostatic interactions in the process of steering of
acetylcholine into the active site of acetylcholinesterases was investigated in this study. A
novel methodology was implemented to simulate the process of recognition of
acetylcholine by Torpedo Californica and both wild type and charge neutralized mutated
Human AChE. The obtained results suggest the important role of coulombic interactions
in the steering process. The steering process of selected irreversible AChE inhibitors was
also simulated supporting the role of electrostatic interactions in the recognition process.
A novel methodology was also employed to model the covalent adducts of
Torpedo Californica and Human AChE's with various organophosphate inhibitors and
the interactions of the organophosphate moieties with the surrounding amino acid
residues of the active sites of the modeled complexes were analyzed.
Finally, an automated docking environment and methodology were designed and
implemented in the prediction of the binding sites in Human AChE of three reversible
acetyl cholinesterase inhibitors, clinically investigated for the treatment of Alzheimer's
type senile dementia. The results of the docking analysis reproduce the potency rank of
the studied inhibitor molecules providing with a wealth of structural information
consistent with similar studies on Torpedo Californica AChE. The developed tools and
methodology can be directly applied in database screening for the discovery of new lead
compounds.
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CHAPTER 1
INTRODUCTION
Acetylcholinesterase is an enzyme of remarkable physiological significance since it
serves to terminate impulse transmissions at cholinergic synapses by rapidly hydrolyzing
the neurotransmitter acetylcholine. It is an extremely effective catalyst, acting on its
natural substrate acetylcholine at rates usually associated with diffusion-controlled
reactions, in accordance with the enzyme's physiological role, a role whose consequences
are of interest to a wide range of backgrounds, the following list being by no means
-

exhaustive. In pharmacotherapy, the treatment of diseases such as Alzheimer's, glaucoma
and myasthenia gravis which have their etiology to malfunctionings in the impulse
termination process, passes through acetylcholinesterase. In the military, the study of
chemical warfare agents is almost exclusively associated with the irreversible reaction of
organophosphate compounds with acetylcholinesterase that causes paralysis and death. in
agriculture, organophosphate insecticides are widely used.
This study is an attempt to shed more light into the functioning of this
biologically important enzyme taking advantage of the enormous advances in the field of
molecular modeling that closely follows those in the computer hardware and software. Of
particular emphasis in this study was the controversial role of the electrostatic interactions
in the process of recognition of cationic ligands by acetylcholinesterases, the irreversible
poisoning of the enzyme by compounds that are used as chemical warfare agents and the
binding of reversible inhibitors/promising drugs in the treatment of Alzheimer's type
senile dementia to Human acetylcholinesterase.
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This thesis is organized into five chapters. In Chapter 2, the focus is on the
controversial role of electrostatic interactions in the process of recognition of the
physiological substrate acetylcholine by the acetylcholinesterases. The history, biological
function and some key structural features of acetylcholinesterases are covered in 2.1. The
literature on the influence of the enzyme's electrostatic field on the rate of diffusional
encounter between the enzyme and the substrate with all the surrounding controversy is
critically reviewed in 2.2. In 2.3, details of the approach used in this part of the study that
involved Torpedo California, Human and charge neutralized mutated Human
acetylcholinesterases are provided and the results with an accompanied discussion follow
in 2.4.
Chapter 3 is devoted to two aspects of the phenomenon of irreversible
organophosphate inhibition of acetylcholinesterases, the simulation of the steering
process of selected irreversible acetylcholinesterase poisons into the enzymes' binding
cavity to evaluate the influence of the enzymes' surrounding electrostatic field and the
modeling of the covalent adducts of the studied organophosphate compounds with

Torpedo and Human acetylcholinesterases to correlate important structural features of the
modeled complexes with the potency of inhibition and the efficiency of the steering
process. An introduction to the military significant phenomenon of irreversible poisoning
of acetylcholinesterases is given in 3.1. The methodology involved in this part of the
study with the obtained results and their discussion are presented in 3.7 and 3.3
respectively.
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The final point of interest of this thesis concerned a systematic docking analysis
of the binding of three reversible acetylcholinesterase inhibitors in Human
acetylcholinesterase and is treated in Chapter 4. The progress in the process of developing
new efficient and selective therapeutic agents in the fight against the Alzheimer's disease
is reviewed in 4.1. The automated docking-based methodology of this part of the study is
given in 4.2 while 4.3 contains the results and their analysis in the identification of the
plausible binding sites and the implications in the area of drug discovery.
Finally.. general conclusions from this work are derived and summarized in
Chapter 5 along with some recommendations for future work.

CHAPTER 2
ELECTROSTATIC INTERACTIONS IN THE PROCESS OF RECOGNITION
OF ACETYLCHOLINE BY ACETYLCHOLINESTERASES
2.1

Structure and Function of Acetylcholinesterases

Cholinesterases constitute a family of enzymes which differ in their substrate specificity
and susceptibility to inhibitors among different species. Depending on their substrate
preference, cholinesterases fall broadly into two types although this division is not
absolute and it holds true more in mammalian than in non-mammalian species.
Acetylcholinesterases (AChE) are the enzymes that preferentially hydrolyze acetyl esters
like acetylcholine (ACh) while butyrylcholinesterases (BChE) are non-specific
cholinesterases that prefer other types of esters such as butyrylcholine.
Acetylcholinesterase (AChE, Acetylcholine Hydrolase, E.C. 3.1.1.7) was
discovered in 1938 by David Nachmansohn. It is a 260-kd enzyme located in the synaptic
cleft and can be readily separated from the acetylcholine receptor (Figure 1). Its
physiological role is the termination of impulse transmission at cholinergic synapses by
rapid hydrolysis of the neurotransmitter acetylcholine. A striking feature of this enzyme
is its very high turnover number of 25,000 s which means that is cleaves an
acetylcholine molecule in 40μs (Stryer, 1988).
Neurotransmitters are extracellular signaling molecules released by the
presynaptic neuron at a chemical synapse that relay the signal to the postsynaptic cell. A
neurotransmitter can elicit either an excitatory or inhibitory response with the kind of
response being determined by the receptor activated by the neurotransmitter and not by
the chemical nature of the neurotransmitter.

4

5

Acetylcholine, the physiological substrate of acetyleholinesterase, is a small
positively charged molecule utilized as a neurotransmitter in the process of nerve impulse
transmission. Synapses in which acetylcholine is the neurotransmitter are defined as
cholinergic synapses.
Acetylcholine has short life span. Once it has been exocytosed into the synaptic
cleft and has transferred its chemical signal to its target receptor, the synapse must be
restored to its original resting state through the destruction of the neurotransmitter. In
spite of the fact that most neurotransmitters are taken up by the presynaptic neuron,
acetylcholine is being enzymatically degraded to acetate and choline by
acetylcholinesterase.
AChE's catalytic mechanism resembles that of a diverse group of proteolytic
enzymes known as the serine proteases. Serine proteases, like trypsin and chymotrypsin,
are the most thoroughly understood family of enzymes and they are characterized by the
possession of a peculiarly active serine residue that is essential for their enzymatic
activity.
This serine residue, identified as Ser200 in Torpedo California AChE, is ideally
positioned (proximity and orientation effects) to carry out the nucleophilic attack of the
carbonyl carbon of the physiological substrate ACh to form a tetrahedral intermediate
(Figure 2). In this acetylation step, the imidazole ring of a neighboring histidine residue
(His440 in Torpedo AChE) takes up the liberated proton forming an imidazolium ion
(general base catalysis). This general basis catalysis is aided by a glutamic acid residue
(Glu327 in Torpedo) that is hydrogen bonded to the histidine residue. The tetrahedral
intermediate has a transient existence, decomposing to the acetyl-enzyme intermediate
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under the driving force of proton donation (general acid catalysis) from His440 with the
leaving amine group being replaced by water from the surrounding solvent. Finally, a
reversal of the previous steps, with the water serving as the attacking nucleophile and
Ser200 being the leaving group, known as the deacylation step, leads to the regeneration
of the enzyme.
One of the landmarks in the study of acetylcholinesterases was the elucidation of
the x-ray crystal structure (Figure 3) to 2.8

A of Torpedo Californica acetylcholinesterase

in 1991 by Joel Sussman's group (Sussman et al., 1991).
Acetylcholinesterase molecule is a homodimer, has an ellipsoidal shape with
dimensions —45A by 60

A by 65 A and belongs to the class of a/13 proteins (a 2 (3,

structure) consisting of a 12-stranded central mixed

p sheet surrounded by 14 a. helices.

The traditional view of the active site of ACNE consisted of two subsites; a
negatively charged 'anionic' site to which the positively charged quaternary nitrogen
moiety of ACh binds and an esteratic subsite containing the actual catalytic residues. A
second 'anionic' site, the 'peripheral anionic' site, around 14

A from the active site, was

proposed on the basis of the binding of long bisquatemary ligands.
The esteratic site was identified as being consisted of Ser200, His440 and a
glutamate residue, Glu327, instead of the usual aspartate residue in serine proteases.
These three residues form a planar array ,constitute the enzyme's catalytic triad and they
are positioned with respect to the rest of the protein as a mirror image of that seen in the
serine proteases.
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The most remarkable feature of this enzyme though is the existence of a deep and
narrow gorge, the 'active site gorge', —20 A long, that penetrates halfway into the enzyme
and widens out close to its base. The catalytic triad is located towards the bottom of that
gorge. The Opt atom of Ser200, which can be seen from the surface of the enzyme, is
located --4A above the base of the gorge. Fourteen aromatic residues line a substantial
portion of the surface of the gorge. These residues and their flanking sequences are highly
conserved among acetylcholinesterases and they may be important in guiding the
substrate into the active site.
No discernible 'anionic' or 'peripheral anionic' binding sites were identified.
Instead, it is now well established that the quaternary nitrogen of the choline moiety binds
through interactions with the

7

electrons of the aromatic ring of the residue Trp84

(constituting what was believed to be an 'anionic' site) while bisquaternary ammonium
ligands in addition interact with the
'peripheral anionic' binding site.

it

electrons of Trp279, the previously called

2.2 Literature Review
Electrostatic fields around the surface of proteins are known to play an important role in
molecular recognition and binding due to the long-range nature of the Coulombic
interactions.
The effect of electrostatic steering was shown to enhance catalytic rates of
superoxide dismutase with superoxide ion (Davis et al., 1991) and of triose phosphate
isomerase with glyceraldehyde-3-phosphate (Luty et al., 1993). On the other hand, global
charge-charge interactions do not appear to contribute to the association of dihydrofolate
reductase with folate or NADPH since although the net charge of enzymes from different
sources varies from +3 to -10 they display equivalent catalytic activity (Bajorath et al.,
1991). Therefore the contribution of the electrostatic properties of an enzyme to its
catalytic activity has to be evaluated for each particular enzyme.
Acetylcholinesterase is an extremely efficient enzyme believed to operate at or
near the diffusion control limit (Quinn, 1987). Amino acid sequences of
acetylcholinesterases from different species indicate that these enzymes carry a net
negative charge ranging from -1 le up to -14e (Doctor et al., 1990). Early estimates from
studies of the dependence of the association rates of AChE with various substrates, led to
the conclusion that electrostatic attraction is a driving force for the rapid binding of ACh
to AChE (Quinn, 1987).
The first theoretical study of the role of electrostatic interactions in the process of
recognition of cationic ligands by acetylcholinesterase was in 1993 from .1. McCammon's
group (Tan et al., 1993). In their study, Tan et al. computed the electrostatic field around
the enzyme by solving the Poisson equation

90

V Φ = 4π/ε ρ

(I)

via a finite difference scheme. The equation relates the electrostatic potential (I) to the
charge density p in the enzyme and the dielectric coefficient c. They modeled the
enzyme-solvent system as a heterogeneous dielectric continuum in which point charges
are embedded. The solvent was modeled as a continuum with a high dielectric coefficient
(c=80) and each atom of AChE as a point charge embedded in a low dielectric (c=2)
sphere. The effect of added salt was not included. The net charge used for the AChE was
-16.
Their results indicated that the electrostatic potential has the general
characteristics of a monopole plus a quadrupole field. Near the enzyme active site the
potential becomes negative while on the side opposite to the active site it becomes
positive. They therefore postulated a mechanism for steering the a positively charged
substrate or inhibitor towards the active site. According to their results, if the substrate is
far from the enzyme, it only sees the net negative charge and is attracted to the enzyme
from all directions. Near the enzyme, the substrate begins to feel the quadrupole field. If
the substrate approaches the active site directly, it is attracted and reacts, if it approaches
the side opposite the active site, it is repelled and then steered toward the active site.
Tan et al. also used Brownian dynamics simulations to calculate the diffusioncontrolled rate constants for the binding of a positively charged ligand to AChE.
Brownian dynamics simulations are used to compute and analyze a large number of
trajectories of one reactant diffusing toward its partner under the influence of any
intermolecular forces. They performed calculations under three different conditions:

ε
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diffusion subject to full electrostatic forces, diffusion subject only to the monopole
moments of the monomers and diffusion without electrostatic forces. For the monopole
calculations a charge of -8 was placed at the center of each monomer. Their results
suggested that electrostatic interactions play a major role in enzyme-substrate encounter.
The diffusion-controlled rate constant increased by an order of magnitude when the
charge on the enzyme was increased by 16 units upon including the monopole
interactions. The rate constant increased by another 65% when the higher moments
(quadrupole) were considered. The rate constant calculated in that study with the full
charge distribution was though 10 times higher than the one calculated by Quinn (Quinn,
1987). The oversimplified model used in that study with the ligand represented by a
sphere and the negligence of orientational criteria were reasoned for the discrepancies.
In 1995, J. McCammon's group, in an attempt to bridge the gap between their
computed rate constants and the experimentally measured ones and improve their
prediction of the dependence of the rate constants on the ionic strength, modified the
model used in the previously performed Brownian dynamics simulations and the criteria
for the encounter of the ligand with the enzyme. The modifications involved improved
representations of the ligands and the electrostatic field of the enzyme. Orientational in
addition to the translational steering effects were considered this time along with
dumbbell-shaped ligand models, consisting of two spheres the diffusion properties and
charge distribution of which approximate those of ACh instead of the bead models they
previously employed. In their published work (Antosiewicz et al., 1995a), they compare
the results on the rate constants calculated for different models of the ligands under the
new electrostatic field model and for different reaction criteria. They concluded that their
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results support the contribution of the electrostatic field to the significant increase of the
encounter rate. It is important to note that the electrostatic field favored one particular
orientation of the dumbbell ligands but it accelerated encounter with the substrate in
either orientation relative to the case of a neutral dumbbell. The steering effect of the
electrostatic field was greater on the dumbbell than on the single-bead ligands. Once
again though the computed rate constants exceeded the experimental values even though
they were lower than the rate constants obtained for the single-bead models. Moreover,
the strong dependence observed experimentally of the encounter rates on the ionic
strength disagrees markedly with the experimental data. Therefore this work didn't
challenge the role of the electrostatic interaction in the recognition process of
acetylcholine by acetylcholinesterase. A combination of Brownian dynamics with
Molecular dynamics simulations was proposed though as a way to overcome the
conformational rigidity imposed on the enzyme.
In 1993, Joel Sussman's group, proposed an 'electrostatic mechanism for
substrate guidance down the aromatic gorge of acetylcholinesterase' (Ripoll et al., 1993).
They evaluated the electrostatic potential and field of ACNE assuming a net charge of -8e
for the x-ray resolved structure of the enzyme. A strong electrostatic dipole was revealed
with a negative potential extending roughly over half of the protein surface and a positive
potential covering the other half The electrostatic dipole was aligned directly along the
axis defining the center of the active site gorge. This indicated that positively charged
molecules, such as the physiological substrate ACh could be drawn toward and clown the
aromatic gorge to the active site. Their results basically supported the results of Tan et. al.
mentioned previously (Tan et al., 1993). The number of charges in the active site gorge is
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very small, just four acidic residues are present, one of which is a member of the catalytic
triad, but there is a marked preponderance of acidic amino acids in the 'northern'
hemisphere lying above the active site triad and a somewhat smaller preponderance of
basic amino acids in the 'southern' hemisphere.
The contribution of the four acidic residues of the active site gorge to the overall
dipole moment was assessed by neutralizing the charges on their side chains. They
realized then that the dipole is generated by the overall charge distribution throughout the
enzyme and is not merely due to the acidic residues in the active site gorge. Since most of
the acidic residues in the 'northern' hemisphere lie behind the residues that line up the
gorge, they proposed that the electrostatic dipole drives the cationic ACh down the gorge
and the aromatic groups provide a series of low-affinity binding sites for the quaternary
choline group, much like what takes place in an affinity electrophoresis column. The
aromatic groups at the same time play a shielding role since a gorge lined with acidic
residues would bind ACh too avidly to the active site triad.
The up to 1993 undisputed role of the electrostatic interactions in the steering of
charged ligands and inhibitors to the active site of the enzyme was shattered in 1994 by
another milestone publication in the field of cholinesterases of experimental data that
suggested that the surface electrostatic properties of ACNE do not contribute to the
catalytic rate, that this rate is probably not diffusion-controlled and that long-range
electrostatic interactions play no role in stabilization of the transition states of the
catalytic process (Shafferman et al., 1994). The authors claim that the assumption of the
catalytic bimolecular rate being diffusion-limited contradicts the fact that the actually
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measured rate constants for various acetyleholinesterases are about an order of magnitude
lower than the expected rates of diffusion-controlled reactions.
To investigate the contribution of the electrostatic interactions to the catalytic rate
of AChE they generated mutant forms of Human AChE in which up to seven of the
surface negative charges located near the rim of the active-site gorge were neutralized. A
gradual shrinking of the electrostatic potential over the 'northern' hemisphere
corresponding to the progressive reduction of the surface negative charge was observed.
Both single and multiple replacements of acidic residues were studied to ensure no
indirect effects such as conformational changes affecting enzyme stability or allosteric
modulation of the active site could mask the specific contribution of the electrostatic
attraction and complicate the interpretation of the kinetic data. Indeed, none of the singlesite replacements had a major effect on the catalytic properties of the resulting enzymes.
The effect though on the enzyme stability of the enzymic forms carrying multiple amino
acid replacements was not assessed in that study.
The catalytic activity of the single- and multiple-site mutants was examined using
the charged substrate acetylthiocholine (ATC) and its isosteric uncharged analog 3,3dimethyl butylacetate (TB) to allow examination of the net effect of charge on the
catalytic properties of the mutated enzymes. These two molecules differ in that the
trimethylammonium moiety is replaced by a t-butyl group and the carbonyl oxygen is
replaced by a sulfur. The kinetics of inhibition of the various mutants were studied also
using edrophonium, a charged, reversible, active-center AChE ligand that is known
(Harel et al., 1993) to interact with regions of the active center similar to those
responsible for the binding of the charged substrate ATC.
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The kinetic constants for reactivity of the mutants towards both the charged and
the uncharged substrates and inhibitor were practically invariant indicating that the
electrostatic attraction doesn't contribute to the reaction rates. Some minor variations in
the values of the Michaelis-Menten constant K,„ were attributed to two specific residues
one of which is known to affect moderately the binding of active-center ligands (Barak et
al., 1994) while the other is located very near the active center.
The conclusion of the work of Shafferman et. al. (Shafferman et al., 1994) that the
rate of the enzyme-substrate reaction is not diffusion-controlled is consistent with the lack
of correlation of the catalytic rate with the charge of the substrate that was previously
reported (Quinn, 1987). They also suggest (Shafferman et al., 1994) that it is possible that
the electrostatic attraction in aqueous solutions is cryptic while in the viscous milieu of
the synaptic cleft it becomes operational. This statement along with the lack of thorough
and careful assessment of the effect of the mutations vicinal to the active-site gorge
studied on the enzymatic stability could be used to challenge the findings reported in this
study.
A yet another Brownian dynamics study inspired by the exciting experimental
findings of the work of Shafferman et. al. (Shafferman et al., 1994) appeared in 1995 by
J. Andrew McCammon and Michael K. Gilson's groups (Antosiewicz et al., 1995b). The
purpose of their work was to investigate whether their previously reported results from
Brownian dynamics simulations, which suggested that the electrostatic steering increases
the hydrolysis rate by increasing the rate of encounter of cationic substrates with the
active site, could be reconciled with the experimental study of Shafferman et al.
(Shafferman et al., 1994) which suggested exactly the opposite. Although their study was
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based on the Torpedo Californica AChE existing crystal structure, the high degree of
sequence homology between Torpedo Californica and Human AChE can provide the
justification for their results. This theoretical study considered the 20 single- and
multiple-site Torpedo Californica AChE homologous mutants of the study of Shafferman
et al. (Shafferman et al., 1994).
They reported that although the induced mutations progressively increase the net
negative charge of the enzyme to zero with a concomitant shrinking of the electrostatic
potential of the enzyme, the magnitude of the dipole moment does not go to zero but falls
off only about 40% while the orientation with the respect to the gorge axis does not
change significantly. They did not, however, observe a clear correlation between the
computed dipole moments of the various mutants and their corresponding measured
apparent bimolecular rate constants. The previous observation of the authors
(Antosiewicz et al., 1995a) that the encounter rate constants for cationic substrates largely
exceed those for neutral ones when the reaction criteria are a short distance inside the
active site gorge suggested that the degree to which the field increases the encounter rate
is likely to correlate best with the fields in the immediate vicinity of the gorge. The
examination of the electrostatic potentials along the gorge axis for both the wild type and
the mutated enzymes showed that the potentials indeed become progressively less
negative as more acidic residues are neutralized but even when all the acidic residues are
neutralized, the potentials along the axis are strongly negative. This fact was reasoned to
explain the agreement of the simulations results with the previous experimental findings
(Shafferman et al., 1994).
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Although the computations in the study of Antosiewicz et al. (Antosiewicz et al.,
199Th) assumed diffusion limitation and predicted electrostatic steering, they reproduced
the experimental results of Shafferman et al. (Shafferman et al., 1994) although the
encounter rate constants for a cationic substrate were found to be significantly larger than
those for a neutral substrate suggesting a significant electrostatic steering effect. The
inherent limitation of this study of course was that the results concerned Torpedo AChE.
Recently, another Brownian dynamics study was published again by J. Andrew
McCammon's group (Antosiewicz et al., 1996) whose objective was to correlate the
calculated rate constants of the charge neutralized mutated Torpedo enzymes considered
in their previous work (Antosiewicz et al., 1995b) with the direction of the dipole
moments of those enzymes.
Their simulations indicated that the modest effects of mutations of surface acidic
residues of Human AChE observed previously experimentally were consistent with the
changes introduced by these mutations in the electrostatic field of the enzyme. The results
obtained revealed that there are no simple correlations between rate constants and such
global quantities as the net charge and the dipole moment. However, for all mutants
characterized by the same direction of dipole moment, the calculated rate constants were
nearly linearly correlated with the number of mutations. Deviations from this correlation
were accompanied by larger changes in the direction of the dipole moment within the
subset of mutants. They claim that their results remain in agreement with the concept of
electrostatic steering by the enzyme. Moreover, they observed that this steering is limited
to relatively short distances from the surface of the protein which could be attributed to
any possible perturbations of the electrostatic field of the enzyme by surrounding (macro)
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molecules. They suggested that the electrostatic steering is accomplished in part by
directing substrate molecules that diffusionally approach the enzyme at the distance of a
few angstroms to the entrance of the gorge and in part by increasing the commitment to
reaction for substrates as they move deeper into the gorge. They warned though that
Human and Torpedo AChE are somewhat different and therefore it couldn't be expected
that mutations of homologous acidic residues have the same effect in both enzymes but
qualitative correspondence might be expected.
This chapter attempts a different approach targeted at the elucidation of the
influence of the electrostatic field surrounding acetylcholinesterases on the process of
steering positively charged substrates or inhibitors into the binding cavity of the enzyme.
Three acetylcholinesterase representatives were studied; Torpedo Californica
acetylcholinesterase, whose x-ray crystal structure has been already elucidated and is
available; Human acetylcholinesterase, whose structure was generated in this study based
on the available structure of the homologous Torpedo Californica AChE; and a charge
neutralized mutated Human acetylcholinesterase, whose structure was also generated
through mutant modeling of the Human AChE. This charge neutralized enzyme which
has seven surface acidic residues mutated has been employed in the experimental study of
Shafferman et al. (Shafferman et al., 1994) which was reviewed above.
The next section describes the methodology used to carry out the investigation of
the role of electrostatic interactions in the substrate steering. This includes the calculation
of the electrostatic potential around acetylcholine, the modeling of Human and mutated
Human AChE and the simulation of the process of steering of acetylcholine into the
active site of the studied enzymes.
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Section 2.4 contains the results obtained from the calculation of the electrostatic
potential of ACh and the simulations of its steering process into the active site gorge
along with the conclusions from this study. A further discussion of the role of
electrostatics in the steering process in view of the results of this investigation.

2.3 Methodology

The x-ray crystallographic coordinates for Torpedo Californica acetylcholinesterase
(Sussman et al., 1991) were obtained from the Brookhaven Protein Databank (PDB Entry
# lace) and the ligand acetylcholine was extracted from the AChE-ACh complex.
The structure of the extracted ligand ACh was minimized to the local minimum
energy state closest to the starting set of atomic coordinates with MAXIMIN2 using
SYBYL 6.2 molecular modeling software (Tripos Inc., 1995) running on a Silicon
Graphics Indigo II workstation. The Powell minimization method of MAXIMIN2 was
utilized which is well suited for a wide variety of problems and is the default
minimization procedure in SYBYL. The Tripos force field (Clark et al., 1989) was used
throughout this study.
The partial charges of the atoms of ACh were calculated using the MNDO
semiempirical molecular orbital method in MOPAC 6.0 (Stewart and Seiler).
Subsequently, the electrostatic potential map around ACh was calculated and displayed
using SYBYL.
The missing atoms from the side chains of 27 amino acid residues (19, 26, 42, 46,
74, 88, 89, 107, 162, 163, 253, 257, 260, 261, 268, 270, 284, 286, 299, 310, 325, 344,
350, 353, 365, 382, 413, 434, 455, 461, 478, 484, 498, 499, 508, 511, 515, 526, 533) in
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the obtained structure of Torpedo Californica AChE were then added with SYBYL.
These are polar surface residues not seen in the electron density map. The orientation of
the added side chains was adjusted to eliminate steric hindrances. The Loop Search
algorithm of SYBYL was then used to construct the missing 486-489 four-amino-acid
segment. The Loop Search facility of SYBYL enables the use of fragments of proteins of
known three-dimensional structure for building of models of unknown protein structures.
The polar hydrogens were added to the structure thus obtained which was then minimized
to achieve good covalent geometry, energetically acceptable hydrogen bonds and total or
near total absence of steric overlaps, until the energy gradient reached a cut-off value of

.
0.5 kcal
mol The modeled structure of Torpedo Californica AChE was used as a template to
generate the three dimensional structure for Human AChE through the Homology
Modeling module of LOOK 2.0 (Molecular Applications Group, 1995). The amino acid
sequences of Torpedo Californica and Human AChE's were aligned using the
Needleman-Wunsch algorithm (Needleman and Wunsch, 1970).
This homology modeling methodology of LOOK is based on the work M. Levitt
(Levitt, 1992 and Levitt, 1983). The polar hydrogens were then added to the structure
which was then minimized with MAXIMIN2 of SYBYL 6.2 until again the energy
gradient
reached a cut-off value of 0.5 kcal mol -Å.
ÅThe three dimensional structure of a charge neutralized mutant Human AChE
enzyme was modeled using again the Homology Modeling module of LOOK. This
enzyme contained mutations of seven acidic surface amino acid residues located in the
rim of the active site gorge as was utilized in the study of Shafferman et al. (Shafferman

Å
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et al., 1994) which was thoroughly discussed previously. The mutations involved were
E84Q, E285A, E292A, D349N, E358Q, E389Q and D390N. This time, the amino acid
sequences of Torpedo Californica AChE and Human AChE bearing these mutations were
aligned and the three dimensional structure of Torpedo Californica was used as a
template again for the modeling of the mutant Human enzyme.
Polar hydrogens were added to the structure of the mutated Human enzyme
obtained through the process described above for the wild type Human AChE and its
geometry was then optimized with MAXIMIN2 of SYBYL 6.2 until the energy gradient
reached a cut-off value . of 0.5 kcal mol The dipole axes of each one of the three AChE's modeled as previously described
and ACh were aligned with SYBYL 6.2 to create the direction of the most favorable
orientation for the interaction between AChE and ACh.
To study the effect of electrostatic interactions in the steering of ACh towards the
active site of each one of these AChE's a code was developed using the SYBYL
Programming Language to drive ACh from a distance of about 35A towards the Ca of the
serine residue of the enzymes' catalytic triad in the direction of the most favorable
orientation, i.e. the direction of the aligned dipole axes, in 1 Å steps. The code calculated
the total, electrostatic, 1-4 electrostatic and van der Waals energies of the AChE-ACh
Å-

complex at each distance while

Ch was rotated around the common dipole axis. The

energy minimum for the most favorable rotation angle at each distance of the center of
mass of the ligand from the C α of the serine of the catalytic triad was then recorded and
the structure of the enzyme-ligand complex for the most favorable rotation angle at each
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step
was energy minimized with MAXIMIN2 to an energy gradient value of 0.5 kcal
Å-m1ol

2.4 Results and Discussion
The amino acid sequences of Torpedo Californica AChE (SwissProt Accession ID:
PO4058) and of Human AChE (SwissProt Accession ID: P22303) were aligned using the
Needleman-Wunsch algorithm (Needleman and Wunsch, 1970) as it is implemented in
the Gap function of GCG 8.0(Genetics Computer Group, 1994) and the generated
alignment is shown in Figure 4. The percent similarity calculated is 62.628 while the
percent identity is 54.096.
The root-mean-square deviation of the Ca of the superimposed structures of
Torpedo Californica and Human AChE's is 0.827 Å (Figure 5).
The alignment of the amino acid sequences of Torpedo Californica (SwissProt
Accession ID: PO4058) and the charged neutralized mutant Human AChE's was also
performed with GCG and is shown in Figure 6. Their percent similarity calculated is
62.116 and the percent identity is 53.754.
The root-mean-square deviation of the Ca of the superimposed structures of
Torpedo Californica and charge neutralized mutant Human AChE's is 0.865Å (Figure 5).
The three dimensional modeled structures of the Human and mutated Human
AChE's were also superimposed (Figure 8). The calculated root-mean-square deviation of
the C α is.0.672Å.

2

The dipole moments calculated for the wild type Human AChE and the charge
neutralized mutant Human AChE based on the models constructed during the course of
this study were 1018 D and 331 D respectively. This means that the charge neutral
enzyme retains only 32.5% of the dipole moment of the wild type enzyme. In the case of

Torpedo Californica AChE studied by Antosiewicz et al. (Antosiewicz et al., 1995b), the
charge neutralized enzyme that contained mutations of amino acid residues homologous
to the ones of the mutated Human AChE retained 64.5% of the dipole moment of the
corresponding wild type enzyme. Consequently, in the case of the Human enzyme, the
effect of the studied mutations on the dipole moment and therefore on the electrostatic
field surrounding the enzyme is more pronounced than in the case of the Torpedo AChE.
The significant amino acid sequence homology between the Torpedo and Human AChE's
therefore should be used with particular caution in any attempt to explain experimental
results concerning the Human enzyme by performing theoretical calculations on the

Torpedo AChE. This is very significant since, by far, in the absence of a crystal structure
for the Human AChE, the results from theoretical calculations on Torpedo AChE were
extrapolated on the basis of sequence homology.
In the all-trans structure of the extracted ligand ACh, generated as described
above, the calculated MNDO partial charges of its atoms suggest that the +1 total charge
of this molecule is not localized on the quaternary ammonium atom as long regarded;
however, it is the result of the contribution of the partial charges of all the atoms. The
calculated electrostatic potential map around ACh is displayed in Figure 9 with the red
contour representing positive electrostatic potential region.

Å
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The complete three dimensional structure of Torpedo Californica AChE is
displayed in Figure 10. Figure 11 is a depiction of the three dimensional structure of the
charge neutralized mutated Human AChE modeled during the course of this study as
described above. The mutated residues near the rim of the active site gorge of the enzyme
are colored purple.
The values of the total, electrostatic, 1-4 electrostatic and van der Waals energies
of the minimized structures for the most favorable rotation angle at each step of the three
complexes studied, Torpedo Californica AChE-ACh, Human AChE-ACh and mutated
Human AChE-ACh, relative to the corresponding energy values of the global energy
minimum, at various distances of the center of mass of the ligand from the Ca of the
serine residue of the enzymes' catalytic triad (whose Oy is located --4Å above the bottom
of the gorge in Torpedo Californica AChE) are presented in Table 1, Table 2 and Table 3
respectively. A perusal of these tables indicates that the electrostatic energy is the
predominant form of energy. The only exception found were the Human AChE - ACh
and mutated Human AChE - ACh complexes at 7, 9 and 10

and at 7, 9 and 11

respectively. This is due to the existence of significant steric overlaps between atoms of
the substrate and the enzymes, in close proximity to the surface of the enzymes, that give
rise to high van der Waals energy values. The presence of the steric hindrances can be
attributed to the relative enzyme-substrate orientation imposed by the alignment of their
dipole axes. In close proximity of the substrate to the enzyme, there may be a slight
deviation from the direction of the most favorable orientation caused by the particular

Å
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features that characterize the behavior of the electrostatic fields of the enzymes very close
to their surfaces.
The total energy values of the Torpedo Californiea AChE-ACh complex relative
to the global energy minimum at various distances of the center of mass of ACh from the
Ca of the Ser200 residue are presented in Figure 12. No change in the energy of the
complex was observed beyond 34 of the center of mass of ACh from the Ca of the
,

'Ser200 residue of the enzyme's catalytic triad. This indicates that the electrostatic field of
ACNE doesn't affect ACh until they are ≈ 34Å apart. As the ligand moves closer, the
energy of the complex slightly changes denoting interaction between enzyme and ligand.
A drastic change in energy was observed between ≈24Å0,sugaetnidh
electrostatic interactions affect the steering of the ligand once it reaches 20-24Å from
the active site, that is only when the ligand is in close proximity to the entrance of the
'active site gorge. Since the energy of the complex doesn't change significantly from
≈34Å to ≈24Å, the steering of the ligand beyond 24 Å appears to be diffusion-controlled.
,

Four other steep changes in energy were observed at ≈ S5Å ≈11Å
,

,,

≈13Å and at ≈15Å

preceding the local minimum energy states at ≈ 10 , Åa≈1ndth2eglo4b
,

energy minimum at

,

,

16 respectively. This indicates the presence of at least four

transition states, at Å,≈1a5ndtheS3xiscofmulpten
,

the catalytic reaction. Only the transition state at 5≈Åisaoctedwh lyi
-,

reaction since it meets orientation and availability requirements for the nucleophilic
attack to take place.

Å
Å
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Figure 13 presents a plot of the total energy values of the wild type Human
AChE-ACh complex relative again to the global energy minimum at various distances of
the center of mass of the ligand ACh from the Ca of the Ser234 of the catalytic triad of

Human AChE. Similarly to the case of Torpedo Californica AChE discussed above, the
energy of the complex remained invariable beyond ≈35Å while a steep energy change
was again observed between ≈21Å and ≈ 24 . These results support again the significance
of the role of the electrostatic interactions in close proximity of the ligand to the active
site gorge of the enzyme.
A number of local energy minima were identified in the case of the Human
enzyme, at ≈ 6 , Åw≈215,≈87ithanedg10lobmu17
,

(16 in Torpedo AChE). Six steep energy changes, suggesting the existence of at least six
transition states, were also located at , ≈12Å, ≈ 16Å and at ≈ 8Å

11Å, ≈13Å and ≈15Å in Torpedo) preceding the local energy minima at
,

11Å, and ≈15Å, the global minimum at ≈17Å and the local minimum at ≈20Å,
respectively. The Human enzyme seems therefore to retain three out of the four transition
states identified in Torpedo Californica, at ≈5Å at ≈12Å (≈11Å in Torpedo) and at ≈16Å
(≈15Å in Torpedo). The transition state at ≈5Å is believed to be again associated with the
atalytic reaction, for meeting the proximity and orientation criteria for a neucleophilic
attack.
Finally, the total energy values relative to the global energy minimum for the
barge neutralized mutated Human AChE-ACh complex studied as a function of the
istance of the center of mass of ACh from the C α of the active site serine residue is

Å
Å
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plotted in Figure 14. Once more, the energy of the complex remains unchanged beyond
,

36A, while no significant change in the energy is observed between 20A and 36A. A
,,,

steep energy change takes place at

,

,

19A. This phenomenon is in contrast to the behavior

seen in Torpedo and wild type Human AChE's where the corresponding steep energy
change takes place between 20 and 24A and between ≈2 1A and ≈24A respectively. This
behavior suggests that the impact of the role of the electrostatic interactions appears when
the ligand is even closer to the active site gorge. This may be attributed to the weakened
electrostatic field as a result of the mutations of the acidic amino acid residues near the
rim of the active site gorge.
The local energy minima identified in the case of the mutant Human AChE were
atÅ (≈

10Å, ,≈12Å, ≈14Å and ≈16Å
≈6Å, ≈8Å, ≈10Å, ≈12Å and ≈16
,

,

in Torpedo, ≈6Å ,

≈8 , ≈11Å, ≈15Å, ≈17Å and ≈20Å in wild type Human). The global energy minimum is

located at ≈ 10 ( ≈ 16 in Torpedo, ≈ 17 in wild type Human). Therefore a shift in the
global energy minimum of the complex is observed relative to the consistently located
global energy minimum in Torpedo and wild type Human AChE which could be a
consequence of a 'delayed' role of electrostatic interactions due to the presence of the
mutations and the altered electrostatic field.
A number of transition states were also identified at ≈6Å ,
Åp≈1recding3thloa ym entiodprvusly.I

≈9,17 nd
Åa

is suggested that the

transition state at ≈ 5 be associated with the catalytic reaction in this case in accordance
with the proximity and orientation requirements for the occurrence of a nucleophilic
attack.
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The results from the simulation of the process of steering of acetylcholine to the
entrance of the active site gorge and into the binding cavity of the three
acetvlcholinesterases studied, indicate the significance of the influence of the charge
interactions on the phenomenon. The consistency that both Torpedo and wild type

Human AChE's have to offer in a number of aspects evaluated, the global minimum
energy location, the location of local minima and transition states and the location of the
diffusion-electrostatics border, the point where electrostatic interactions become
effective, is very significant for a number of reasons.
It first serves the validity of the homology-based model generated in the course of
this study. The modeling of the three dimensional structures of enzymes in the absence of
their x-ray image, using a variety of methods developed for the purpose, is a dream come
true for the field of protein structure prediction, yet undoubtedly a remedy which should
be treated with caution. Second, the observed agreement in the behavior of both the

Torpedo and the wild type Human enzymes is not only important for the phenomenon
studied here, suggesting the similarity in the functioning of the two enzymes, but it also
adds credibility to the geometry of the predicted structure on which the entire study is
based.
The observed consistency also serves to identify the different behavior exhibited
by the mutated Human enzyme as a consequence of the weakened electrostatic field of
the enzyme caused by eliminating the negatively charged amino acid residues near the
rim of the active site gorge.

A summary and a more complete discussion of the influence of the Coulombic
interaction is attempted in 3.3 where the results from the simulation of the steering
process of some irreversible inhibitors become available.

CHAPTER 3
IRREVERSIBLE ORGANOPHOSPHATE INHIBITION OF
ACETYLCHOLINESTERASES: STRUCTURAL AND ELECTROSTATIC
ASPECTS
Introduction

3.1

Acetylcholinesterases are the main targets of organophosphorous pesticides, insecticides
and cholinergic nerve agents. Inhibition of acetylcholinesterases by organophosphates
occurs through phosphorylation of the active site serine and often leads to paralysis and
death (Aldridge and Reiner, 1972). The acetylcholinesterase-organophosphate conjugates
can then undergo postinhibitory processes, the nature and extent of which depend upon
the structure of the inhibitor and the particular enzyme. Spontaneous reactivation through
displacement of the phosphoryl moiety from the active site is usually very slow (Main,
1976). However, reactivation of phosphorylated cholinesterases is possible using
nucleophilic agents such as atropine and oximes that are used in the therapy of
organophosphate poisoning (Aldridge and Reiner, 1972). However, after phosphorylation
by certain organophosphate compounds, acetylcholinesterases progressively lose their
ability to be reactivated according to first-order kinetics. This process called 'aging' is
due to acetylcholinesterase-mediated dealkylation, through alkyl-oxygen bond scission,
of an alkyl/alkoxy group on the organophosphate moiety, resulting in a formal negative
charge in the acetylcholinesterase-organophosphate conjugate (Berman and Decker,
1986). The phenomenon of aging is particularly pronounced for acetylcholinesteraseorganophosphate conjugates in which the organophosphate moiety contains a secondary
alkyl group such as isopropyl or pinacolyl group (Aldridge and Reiner, 1972).
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The cleavage of the C-O bond may be promoted by the negative charge on the
glutamate adjacent to the phosphorylated serine (Qian and Kovach, 1993) although it
appears that other residues involved in the stabilization of the functional architecture of
the active center play a role in this reaction. A salt bridge formed between the P-0 of the
-

dealkylated organophosphoryl moiety and histidine of the catalytic triad could be
responsible for resistance of "aged" acetylcholinesterases to reactivators (Harel et al.,
1991).
Although the aging process is understood on the basis of a carbonium ion
mechanism and depends on the phosphorous stereochemistry in the conjugates, the role
of the enzyme environment in facilitating the process is not well understood.
The objective of this chapter is two-fold; to investigate the role of the electrostatic
interactions in the steering process of selected organophosphate compounds into the
active site gorge of Torpedo Californica and Human Acetylcholinesterases as well as the
interactions of the organophosphate moiety in the acetylcholinesterase-organophosphate
conjugates with the surrounding amino acid residues of the poisoned enzymes. The
results of the structural investigations performed are also correlated with published
experimental data of the phosphorylation and aging rate constants of the studied nerve
agents.
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3.2 Methodology
The three dimensional structures of the two organophosphate inhibitors under
investigation in the present study, Sarin (isopropyl methylphosphonate) and DFP
(diisopropylphosphorofluoridate) (Figure 15) were built by using the Build module of
Insight (Insight 95.0, Biosym 1995). The phosphorous atom in Sarin constitutes a
stereocenter and the two corresponding enantiomers are designated as Sarin PR and Sarin
PS according to the Cahn-Ingold-Prelog system. The geometries for all these three small
molecules, Sarin PR, Sarin PS and DFP, were then energy minimized to their nearest
local energy minimum states, with MAXIMIN2 using SYBYL 6.2 molecular modeling
software (Tripos Inc., 1995).
To identify low energy conformers for the three molecules under study
overcoming energy barriers, a protocol constituted by molecular dynamics and energy
minimization was devised. In that protocol, the local energy minimum conformations
primarily obtained for the three molecules were subjected to 100 runs of a simulated
annealing schedule implemented through the Dynamics module of SYBYL 6.2. The
schedule involved heating of the molecules to 2000 K for 5000 ps and subsequent
exponential cooling to 300 K for 2000 ps. The results of the simulated annealing
calculations were then analyzed through a SYBYL Programming Language code that
subjected all the generated geometries to energy minimization using MAXIMIN2. The
lowest energy conformation for each molecule was then selected and the MNDO partial
charges of its atoms were subsequently calculated with MOPAC 6.0 (Stewart and Seiler)
implemented through SYBYL. The electrostatic field generated as a result of those

32

charges was also calculated and displayed in the form of isopotential contours for each
one of the inhibitors employing SYBYL (Figure 15).
For the elucidation of the role of the electrostatic interactions in the process of
recognition of these three irreversible inhibitors by acetylcholinesterase, the methodology
followed in the study of the steering process of acetylcholine into the active site of
acetylcholinesterase and described in the section 2.3 was undertaken. In the case of the
organophosphate inhibitors only the Torpedo Californica and the wild type Human
enzymes were employed. The low energy conformations obtained as described above
were employed in this part of the study.
To obtain the geometries of the covalent adducts of these irreversible
acetylcholinesterase inhibitors with Torpedo Californica and Human AChE's, 50 runs of
the simulated annealing schedule described above were performed to each one of the
small molecules. A SYBYL Programming Language code was then developed that
generated the covalent adduct of each one of the enzymes with each one of the
conformations generated for each inhibitor by the simulated annealing calculations. The
adduct formation involved simply the creation of a covalent bond between the 0 7 of the
serine residue of the active site and the phosphorous atom of inhibitor with the removal of
the halogen substituent of the organophosphate and of the polar hydrogen of the hydroxyl
of the side chain of the active site serine.
For each adduct, the torsional angle associated with the 0,- P bond was then
varied and the energy of the adduct was recorded for each value of this torsional angle.
The conformation corresponding to the torsional angle of the lowest energy adduct was
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subsequently selected for each enzyme and each inhibitor. Six structures were thus
obtained, Torpedo - Sarin PR, Torpedo - Sarin PS, Torpedo - DFP, Human - Sarin PR,
Human - Sarin PS, Human - DFP which were subjected to energy minimization to a
gradient of 0.05 kcal mol-1 Å-1 This methodology constitutes a very fast, less resource.

demanding yet reliable alternative to the use of molecular dynamics for the generation of
the three dimensional models of the covalent adducts of acetylcholinesterases with
irreversible organophosphate inhibitors. Furthermore, the use of the simulated annealing
calculations and the covalent bond's torsional angle variation conserves the exploration
of space for the covalent modification - modified side chain of the active site serine while
holding the rest of the enzyme rigid.

3.3 Results and Discussion

The structures of the three organophosphate inhibitors considered in the study of the
effect of the electrostatic interactions in the process of irreversible poisoning of
acetylcholinesterase are shown in Figure 15. These are the geometries for Sarin PR, Sarin
PS and DFP, obtained through the combination of the use of simulated annealing and
energy minimization calculations described in the previous section. The calculated
electrostatic maps for these molecules are also depicted in Figure 15. All three inhibitors
are polar molecules and the red and blue contours represent negative and positive
electrostatic potential regions respectively.

Å
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Aeetyleholinesterase-arganophosphate Conjugates
In the modeled three dimensional structure of the Torpedo Californica AChE - Sarin PR
adduct (Figure 16), the phosphonyl oxygen forms a hydrogen bond (1.58 A) with the
amide hydrogen of Gly119 maintaining close contacts to the amide hydrogens of the rest
two members of the enzyme's 'oxyanion hole', Gly118 (2.75

) and A1a201 (2.97 ).

The Oy of the phosphorylated Ser200 residue also hydrogen-bonds with the amide

hydrogen of Ala201 (1.69 ). G1u199, whose negative charge has been proposed to
stabilize the resulting carbonium ion, is located very distantly from the leaving isopropyl
group and the two oxygens of its sidechain hydrogen-bond with the amide hydrogen of
Gly118 (1.67 and 2.80 ). The methyl and isopropyl substituent groups of the
organophosphate moiety are engaged in hydrophobic interactions with the aromatic
sidechains of Trp84 and Phe331, Phe288, Phe290 and Trp233 respectively. The distance
of the N ε 2 atom of the His440 residue of the enzyme's catalytic triad from the alkylated
oxygen is 2.70

.

In the Torpedo Californica AChE-Sarin PS adduct (Figure 17), which is higher
energetically than the Torpedo Californica AChE-Sarin PR conjugate analyzed above,
the phosphonyl oxygen forms again a hydrogen bond (1.61

) with the amide hydrogen

of G1y119 and is located close to Gly118 (3.53 A from the amide hydrogen) and A1a201
(2.92 A from the amide hydrogen). The Oy of the phosphorylated Ser200 residue forms a
hydrogen
ε bond (1.70 ) with the amide hydrogen of A1a201 and is 3.18 A away from the
2 atom of His440. Glul 99 is in this adduct closer to leaving isopropyl group while the
NE2 atom of the His440 is 2.93

away from the alkylated oxygen atom of the

Å
Å
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phosphonyl moiety. The methyl and isopropyl groups of the phosphonyl moiety interact
with the aromatic sidechains of Trp233, Phe290, Phe288 and Phe331 and Trp84
respectively.
The phosphonyl oxygen in the Human AChE-Sarin PR conjugate (Figure 18),
forms a hydrogen bond (1.64 ) with the amide hydrogen of Gly153 (homologous to
Gly119 in Torpedo Californica AChE) and interacts with the amide hydrogens of Gly152
(3.08

) and A1a235 (3.15

). G1y152 and Ala235 are homologous to the Gly118 and

Ala201 residues of the oxyanion hole of Torpedo Californica AChE. The Oy of the
phosphorylated active site Ser234 forms a hydrogen bond (1.66 ) with the amide
hydrogen of Ala235 and is located 3.35 A away from the N ε 2 atom of active site His478.
The distance between the alkylated oxygen and the N ε 2 atom of active site His478 is 2.69

A in this adduct. Glu233, which is homologous to Glul99 in Torpedo Californica AChE,
is located distantly to the leaving isopropyl group but it forms a hydrogen bond (l.59 A)
with the amide hydrogen of Gly152. The isopropyl moiety of the organophosphate
engages in hydrophobic interactions with the aromatic sidechains of Trp267, Phe328,
Phe326 and Phe369 (which are homologous to Trp233, Phe290, Phe288 and Phe331
amino acid residues respectively of Torpedo Californica AChE).
The Human AChE-Sarin PS conjugate is characterized by a lower energy than the
corresponding conjugate with Sarin PR (Figure 19). The phosphonyl oxygen forms a
hydrogen bond (1.59 A) with the amide hydrogen of Gly153 interacting with the amide
hydrogens of Glyl52 (3.88 ) and Ala235 (3.13 ). The Oy of the phosphorylated active
site Ser234 forms a hydrogen bond (l.72 A) with the amide hydrogen of A1a235. The
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distance of the alkylated oxygen atom from the Nε2 atom of the active site His478
residue is 3.41

while the Glu233 residue is ~ 4

away from the leaving isopropyl

group. The methyl group of the phosphonyl moiety interacts with the aromatic sidechains
of Trp267, Phe328, Phe326, Phe369 and His478.
The phosphonyl oxygen in the Torpedo Californica AChE-DFP adduct (Figure
20), forms a hydrogen bond (1.60
and 3.16

) with the amide hydrogen of Gly119 19 and is 2.64

away from the amide hydrogens of Gly118 and Ala201 respectively. The Oy

of the phosphorylated active site Ser200 residue forms a hydrogen bond (1.66
amide hydrogen of Ala201 and is 3.54

) with the

away from the N ε 2 atom of His440. The

distances of the N ε 2 atom of His440 from the alkylated oxygen atoms are 3.01 and 4.11

A. Glu199 is located close to the isopropyl group (3.53 A) whose corresponding alkylated
oxygen is further away from the N ε 2 atom of His440 and it is involved in a hydrogen
bond network with Gly118 (1.64

and 2.71 ) and Gly117 and Tyr130. Only the

isopropyl group whose corresponding alkylated oxygen is closer to the Nε2 atom of
His440 engages in hydrophobic interactions with the aromatic sidechains of Phe288,
Phe331, Trp233, Phe290 and His440.
Finally, in the Human AChE-DFP conjugate (Figure 21), which is energetically
higher than the Torpedo AChE-DFP adduct, the phosphonyl oxygen forms a hydrogen
bond (l.59 A) with the amide hydrogen of Gly153 and is located 3.02 and 3.07

away

from the amide hydrogens of Gly152 and Ala235 respectively. The Oy of the
phosphorylated Ser234 residue of the active site forms a hydrogen bond (1.70
amide hydrogen of Ala235 and is 3.28

) with the

away from the Nε2 atom of the His478 residue
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of the catalytic- triad. Both alkylated oxygens are located within 2.88
Nε2 of the His478 residue. Glu233 is 3.95

away from the

away from the closest isopropyl moiety and

it forms a hydrogen bond with the amide hydrogens of Gly152 (1.59

) and Gly151 (1.6

). The isopropyl group more distantly located from the Glu233 residue interacts with the
aromatic groups of Phe369, Phe326, Trp267, Phe328 and His478.
The interactions identified above of the various organophosphate moieties studied
with the neighboring amino acid residues of the poisoned enzymes are summarized in
Table 4 and are in excellent agreement with previously published results (Qian et al.,
1993, Ordentlich et al., 1993, Barak et al., 1992).
For the adducts of Sarin PR and Sarin PS with the Human ACNE, the previously
observed (Barak et al., 1992) more unfavourable energy of the Sarin PR adduct is
successfully reproduced. Since the distance of the N ε 2 atom of the His amino acid
residue of the catalytic triad from the alkylated oxygen atom of the phosphonyl moiety is
indicative of the facilitation of aging, our results indicate that the proton transfer and
therefore the aging process most readily occur in the Human-Sarin PR adduct than in
Human-Sarin PS. This conflicts with the results of Barak et al. (Barak et al., 1992). The

distance of the N ε 2 atom of the active site His from the alkylated oxygen of the
acetylcholinesterase-organophosphate adducts can be used to compare the aging tendency
of the conjugates.
Simulation of the Steering Process

The values of the total, electrostatic, 1-4 electrostatic and van der Waals energies of the
minimized structures for the most favorable rotation angle at each step, obtained with the
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methodology described in detail in Section 2.3, of the six complexes considered, Torpedo

Californica AChE - Sarin PR, Torpedo Californica AChE - Sarin PS, Torpedo
Californica AChE - DFP, Human AChE - Sarin PR, Human AChE - Sarin PS, Human
AChE - DFP, are presented in Tables 5-10. These values, which are relative to the
corresponding energy values of the global energy minimum, are given at various
distances of the center of mass of the inhibitors from the Ca of the serine residue (Ser200
for Torpedo and Ser234 for Human AChE) of the enzymes' catalytic triad.
As mentioned in Section 2.4, in the case of acetylcholine, a positively charged
molecule, the electrostatic energy is the predominant form of energy in the steering
process of acetylcholine into the active site of Torpedo Californica AChE while in the
cases of the wild type and charge neutralized mutant Human AChE's the presence of
significant steric overlaps in close proximity to the surface of the enzyme results in high
van der Waals energy values near the surface of the enzyme and in the predominance of
this form of energy. Although the surface morphology of the enzyme can be the cause of
those steric overlaps, the expected difference in the direction of the aligned dipole
moment axes of the enzyme - ligand system can also function as a major contributor.
A perusal of the Tables 5-10 indicates that the electrostatic energy is by large the
predominant form of energy in all six cases studied. There are three notable though very
isolated exceptions to the above statement, in the Torpedo AChE - Sarin PR, Torpedo
AChE - DFP and the Human AChE - DFP complexes with the steric overlaps appearing
at 16, 15 and 10

A respectively. As mentioned previously, these phenomena are probably

the result of the modified direction of the aligned dipole moment axes of the complexes.
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Also the values reported reflect the energy minimization to which the complexes were
subjected, which leads to the local energy minimum closest to the initial conditions.
These phenomena occur however at distances very close to the active site gorge and
cannot affect any conclusions concerning the behavior at the diffusion-electrostatics
border region.
The total energy values of the Torpedo Californica AChE - Sarin PR complex
relative to the global energy minimum at various distances of the center of mass of Sarin
PR from the Ca of the Ser200 residue are presented in Figure 22. The total energy of this
complex is constant beyond 35

A and as the inhibitor moves closer to the enzyme, the

energy of the complex changes only slightly until enzyme and inhibitor are 24

A apart.

This indicates that the steering of Sarin PR appears to be diffusion - controlled beyond 24

A. This is in agreement with the observed behavior of the Torpedo AChE - ACh complex
reported in Section 2.4. A steep energy change occurs at 24

A suggesting that the

electrostatic interactions affect the steering of the inhibitor when it is in close proximity
to the entrance of the active site gorge of the enzyme. The global energy minimum of the
complex is present at 18 A versus at 16

A in the case of acetylcholine, the natural

substrate of the enzyme. A number of energy minimum states proceeding steep energy
changes is indicative of the existence of multiple transition states and therefore of
multiple steps in the catalytic reaction with Sarin PR preserving the pre-global minimum
point transition state behavior exhibited by acetylcholine. The trend observed for the
electrostatic energy values of the complex resembles that of the total energy values since,
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as aforementioned, the electrostatic energy is the predominant form of energy. The only
difference exists at 16

and its etiology was covered also above.

Figure 23 presents the graphical representation of the relative total energy values
of the Torpedo AChE - Sarin PS complex, versus the distance of the center of mass of
Sarin PS from the Ca of the Ser200 residue of Torpedo AChE. The global energy
minimum of the complex is present at 17

(versus at 18

in Sarin PR and at 16

in

acetylcholine). The phenomenon of the multiple transition states - multiple transition
steps in the catalytic reaction is also present here with two out of the three pre-global
minimum transition states of the acetylcholine being conserved. Again in the case of
Sarin PS, the total energy of the complex remains constant beyond 35 A, while it is
effectively invariant between 22
experienced at 24

and 35

now appears at 22

and the steep change in energy, previously

. The significant identity in the trends of the total

and the electrostatic energy values of the complex supports the predominance of the
electrostatic energy in the steering process.
The results from the simulation of the steering process of DFP into the active site
of Torpedo AChE are presented in Figure 24. The first notable difference with the
behavior seen so far for Sarin and ACh is the location of the global minimum at 11
in acetylcholine, 18

in Sarin PR and 17

in Sarin PS). The energy of the complex is

even in the case of this inhibitor constant beyond 34
23

(16

and effectively invariant between

and 34 . The total and electrostatic energy values exhibit the previously observed

similarity in their trends as a result of the predominant role of the electrostatic energy.
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We start analyzing the steering processes of the three inhibitors into the active site
of the Human AChE considering Sarin PR. The plot of the relative total energy values
with the distance of the center of mass of Sarin PR from the Ca of the Ser234 of the
Human AChE is given in Figure 25. The global energy minimum of the complex is
located in this case at 15

(18

in the complex with Torpedo, 17

in the complex

Torpedo AChE - ACh). The relative total energy of the complex is consistently constant
beyond 34

exhibiting only slightly changes between 22

and 34

, behavior which has

been invariantly experienced for all three inhibitors and the natural substrate with both
the Torpedo and the Human AChE. The pattern of the local energy minimum states is
very similar with the one in the Human AChE - ACh case with the trends of the total and
electrostatic energy values being identical in the case of Human AChE - Sarin PR due to
the predominant role of the electrostatic energy in the steering process.
Figure 26 contains the plot of the relative total energy values of the Human
AChE - Sarin PS complex as a function of the distance of the center of mass of Sarin PS
from the Ca atom of the Ser234 residue of the active site of Human AChE. A shift in the
location of the global energy minimum, this time found at 11
it consistently resided within 1 - 2

from 16

is surprising since so far

. No surprises though in the location of the

diffusion - electrostatic energy border region, with constant energy beyond 33
steep energy change happening at 22

and the

signaling the commencement of the electrostatic

energy affecting the energetics of the steering process. The pattern of the locations of the
local energy minimum states is within 1 - 2
AChE - Sarin PS is considered.

preserved when the pattern of the Torpedo

Å
Å
42

Finally, the graphical representation of the relative total energy values for the
Human AChE - DFP complex with the distance of the inhibitor from the active site gorge

of the enzyme is given in Figure 27. Two significant deviations from an overall similar
picture in the behavior of the inhibitors and the natural substrate during their steering
process are observed, the location of the global energy minimum of the complex at 5
and the absence of the steep character in the energy change signaling the "take-over" of
the electrostatic interactions from the diffusion-controlled regime, at 21

. This is also

the only difference in the trends of the total and electrostatic values.
The results of the simulation of the steering process of acetylcholine and the three
irreversible organophosphate acetylcholinesterase inhibitors into the active site gorge of
Torpedo Califórnica and Human acetylcholinesterases have been summarized in Table 11

to further facilitate their proceeding evaluation. The results have been categorized
according to the global energy minimum location, the location of the various transition
states and the diffusion-electrostatics border which signifies the 'take-over' of the
coulombic interactions from the pure diffusional movement of the small molecules.
The location of the diffusion-electrostatics border is consistently present within
1-2

from 23

. The only notable exception existing the charge neutralized mutated

Human AChE and has been attributed (section 2.3) to the weakened electrostatic field of
the enzyme.
The location of the global energy minimum of the complexes follows a more
complicated behavior. The global energy minimum for DPP is consistently present at
very close distances of the inhibitor from the enzyme, closer than in the case of Sarin and
ACh. This could be attributed to the very low affinity of DFP for acetylcholinesterases
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relative to the affinity of Sarin and the natural substrate. The exception in this trend
though is in the case of Sarin PS in the Human ACNE when it is known that
acetylcholinesterases exhibit a stereoselectivity towards the S isomers.
With the exception of the cases just described above, the small molecules
investigated exhibit a similar behavior during the simulation of the steering process. More
significantly, our results support the crucial role of the coulombic interactions in the
recognition process. A further and more critical consideration of the effect of the induced
mutations in the human enzyme on the electrostatic field and the architecture of the active
site of the enzyme is necessary to ensure the preservance of the structural integrity and
the credibility of the published experimental data that deny the influential role of
electrostatic interactions in the steering process. A preliminary investigation in the course
of this study based on the solvation energy calculations of the wild type and the charge
neutralized mutant human enzymes indicates a possible 'refolding' of the mutant enzyme
which could be held responsible for the surprising experimental results of Shafferman et
al. (Shafferman et al., 1994).

CHAPTER 4
AN AUTOMATED DOCKING ANALYSIS OF SELECTED REVERSIBLE
INHIBITORS IN HUMAN ACETYLCHOLINESTERASE
4.1

Literature Review

The principal biological role of acetylcholinesterase is to terminate impulse transmission
at cholinergic synapses by rapid hydrolysis of the neurotransmitter acetylcholine. One
strategy to enhance cholinergic neurotransmission is to inhibit acetylcholinesterase.
Anticholinesterase agents are therefore of therapeutic importance and they are currently
under active consideration for managing Alzheimer's disease. Reversible
acetylcholinesterase inhibitors have been tested as alternative drugs for Alzheimer's
disease and produced some mixed results but suggest that these agents may be able to
enhance memory in patients with Alzheimer's type senile dementia.
Different chemical classes of reversible acetylcholinesterase inhibitors have been
synthesized and evaluated as possible therapeutic agents in the treatment of Alzheimer's
type of dementia. Treatment with 1,2,3,4-tetrahydro-9-aminoacridine (THA) has
demonstrated moderate but significant efficacy in Alzheimer's type senile dementia.
THA was recently approved by the FDA becoming the first available treatment for
-

Alzheimer's disease in the United States. However the aminoacridines suffer from doselimiting hepatotoxic effects which are believed to be structure related. 1-benzyl-4-[(5,6dimethoxy-1-indanon-2-yl)methyl]piperidine (E-2020) has attracted much attention as a
possible therapeutic agent in the treatment of mild or moderate forms of Alzheimer's
disease. E-2020 is readily synthesized and has higher potency in inhibiting
acetylcholinesterase, higher selectivity for acetylcholinesterase versus
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butyryicholinesterase and longer duration of action in comparison with tacrine (THA) and
appears also to be devoid of the unfavorable side-effect profile of THA because of its
novel benzylpiperidine structure. E-2020 has successfully completed phase III clinical
studies in the United Stated for treatment of senile dementia disease.
A primary goal behind the synthesis of new series of acetylcholinesterase
inhibitors has been to overcome the serious, potentially lethal side effects of short
duration of action and a narrow therapeutic window of existing anticholinesterase agents
towards the development of more effective and selective compounds. Ligand - receptor
docking analysis along with structure - activity relationship data can aid significantly the
rational drug design process providing further insight into the relationship between the
biological activity and the structure of various anticholinesterase agents through an
understanding of the key modes of interactions of the ligand with the receptor.
The availability of the crystal structure of the receptor Torpedo Californica
acetylcholinesterase (Sussman et al., 1991) provided a wealth of information regarding
the existence of multiple ligand binding sites and the functionality of a number of amino
acid residues in those sites. A good fit of the extended all - trans conformation of
acetylcholine was obtained by manual docking (Sussman et al., 1991). The acyl group
was positioned to make a tetrahedral bond with the Oy of the Ser200 residue of the
catalytic site of the enzyme, while the quaternary group of the choline moiety was placed
within van der Waals distance 3.5 A) of Trp84. The model suggested that the ester
oxygen may interact with the imidazole of His440. Glu199, which was suspected of
serving as an anionic component of the substrate - binding site, appeared to make close
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contacts (~ 3 ) both to one of the quaternary methyl groups and to the a-carbon of the
choline moiety.
It has been proposed that the active site of acetylcholinesterase comprises an
esteratic subsite, containing the catalytic machinery of the enzyme and an 'anionic'
subsite which binds the quaternary group of acetylcholine while the presence of a second,
'peripheral' anionic subsite, distal to the active site was also postulated. The crystal
structures of the complexes of Torpedo Californica acetylcholinesterase with three
reversible inhibitors, EDR [ethyl(3-hydroxyphenyl)dimethylammonium], THA and
decamethonium (DECA) showed the presence of Trp84 and Phe330 in the 'anionic'
subsite and suggested that a distal residue, Trp279, near the top of the gorge is also
involved in ligand binding and may be part of the 'peripheral' anionic site (Harel et al.,
1993 and Silman et al., 1993). In the case of DECA (Figure 15), both quaternary groups
are in van der Waals contact with tryptophan indole rings. One is apposed to that of
Trp84 at the base of the gorge and the distal quaternary group is similarly apposed to the
indole ring of Trp279, 12

distant, at the top of the gorge. In edrophonium (EDR)

(Figure 15), the quaternary group nestles adjacent to the indole of Trp84, a position
virtually equivalent to that of the proximal quaternary group of DECA. The m-hydroxyl
group is positioned between NE2 of His440 and 07 of Ser200, making hydrogen bonds of
3.0 and 3.5
a 3.5

respectively, to two of the three members of the catalytic triad. There is also

hydrogen bond to N of Gly119 which is part of the oxyanion hole of

acetylcholinesterase. THA (Figure 15) was found to be stacked against Trp84, its ring
nitrogen hydrogen-bonding to the main - chain carbonyl oxygen of His440. Its amino
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nitrogen forms a hydrogen bond to a water molecule. In all three complexes, the only
residue undergoing a conspicuous conformational change is Phe330. THA is
'sandwiched' between the rings of Phe330 and Trp84.
Pang et al. performed automated docking studies to predict the binding sites of
Huperzine A (Figure 15), one of the most potent and selective reversible inhibitors of
acetylcholinesterase (Pang et al., 1994a). Their docking strategy, accomplished through
their in-house developed code SYSDOC, allowed for flexibility of both the ligand and
the receptor to permit conformational changes upon binding and accounted for steric,
electrostatic, hydrogen bonding and cation - π interactions, which are very important in
the binding of acetylcholinesterase. Molecular flexibility was accomplished by generating
complexes with different conformers of the guest and the host. A systematic search
procedure was used to obtain the different guest conformers while for the host, a series of
molecular dynamics calculations was performed, in the presence of water molecules in
the binding cavity to prevent shrinkage or collapse of the binding site during the
dynamics simulations. In each of the derived complexes, the guest was systematically
translated and rotated in the putative binding pocket of the host, within a box
encompassing the space confined by the 14 aromatic amino acid residues on the surface
of the gorge of acetylcholinesterase, to evaluate energetically favorable binding sites for
each available conformation of the host - guest pair. The affinity of binding in the
docking study is estimated from the potential energy of the complex relative to the
potential energies of the guest and host in their free state, assuming that the differences in
entropy and solvation energies between two binding sites can be neglected. The effect of
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the solvent was not included in the calculations. A single low-potential-energy conformer
of Huperzine A (HA) was generated with systematic search and 69 different conformers
of Torpedo Californica AChE with the molecular dynamics simulations. SYSDOC
revealed that HA binds to the bottom of the gorge in of Torpedo Californica AChE above
Trp84 (catalytic domain) and to the opening of the gorge near Trp279 (peripheral
domain). Three partially overlapping subsites were identified in the catalytic domain,
differing in the hydrogen bonding motif (i.e., the lactam hydrogen atom of HA forms a
hydrogen bond with the hydroxyl oxygen atoms of Tyrl121 in subsite 1, Tyrl 30 in subsite
2 and Ser122 in subsite 3; the pyridone oxygen atom of HA forms a hydrogen bond with
the peptide hydrogen atoms of Gly119 in subsite 1, Ser124 in subsite 2 and Asp72 in
subsite 3). These subsites share the cation - π interactions of the ammonium group of HA
with the aromatic groups of Trp84 and Phe330 and the ionic interactions of the
ammonium group with the carboxyl groups of Asp72 and Glu199. In the peripheral
domain there is one site where the ammonium group of HA partially interacts with the
indole ring of Trp279 and is exposed to the solvent, possibly forming hydrogen bonds
with solvent molecules. At this site, the amide hydrogen atom of HA forms a hydrogen
bond with the carbonyl oxygen atom of Arg289 and the pyridone oxygen atom of HA
forms a hydrogen bond with the hydroxyl hydrogen atom of Ser286.
A novel new class of acetylcholinesterase inhibitors are the indanone - piperidine
derivatives of which E-2020 (Figure 15) shows potent inhibitory action in both in vitro
and ex vivo studies. The IC 50 of E-2020 in vitro is 5.3 nM as compared to THA (52 nM)
and physostigmine (0.43 nM). E-2020 inhibits acetylcholinesterase 570 - fold more
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selectively than butyrylcholinesterase. A number of quantitative structure - activity
relationship studies have been published before the availability of the crystal structure of
acetylcholinesterase, focusing on the substituted indanone and benzylpiperidine rings of
indanone-benzylpiperidine reversible inhibitors of acetylcholinesterase (Cardozo et al.,
1992a and Cardozo et al., 1992b). Pang et al. employed their SYSDOC strategy to
perform a docking analysis of E-2020 (Pang et al., 1994b). In terms of size and
flexibility, E-2020 resembles DECA which bonds into the acetylcholinesterase cavity

spanning the whole gorge with its two ammonium groups interacting with Trp84 at the
bottom and Trp279 at the opening of the gorge. E-2020 possesses one ammonium group
though which may interact with either Trp84 or Trp279. It also contains two aromatic
functional groups and exhibits no stereoselectivity (both the R- and S-isomers are equally
active). In their docking simulations, Pang et al. utilized a pre-E-2020 lacking the two
methoxy groups to overcome the computational burden of the large number of torsional
angles present. Their systematic search produced 120 different conformers of (R)-pre-E2020 and 104 different conformers of (S)-pre-E-2020 which were docked into the 69
different conformers of Torpedo Californica AChE obtained with the molecular
dynamics simulations. The pre-E-2020 docking revealed that 36 different conformers of
the (R)-isomer and 24 different conformers of the (S) - isomer possess suitable backbone
conformation to fit into the gorge of AChE. Then the docking of E-2020 was performed
by adding the two missing methoxy groups. The docking studies revealed that (R)-E2020 possesses three overlapping binding sites and that at each site it spans the whole
gorge. Sites I and II are more favorable than site III based on the calculated binding
energies. At site I, the ammonium group interacts with the aromatic groups of Trp84,
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Phe330 and Tyr334 as well as the carboxy119 group of Asp72; the phenyl group interacts
with the aromatic groups of Trp84 and Phe330; the indanone moiety interacts with the
aromatic groups of Tyr70, Tyr121, Trp279 and Phe290; the carbonyl oxygen atom forms
a hydrogen bond with the amide hydrogen atom of Phe288; and the proton at the
piperidine nitrogen forms a hydrogen bond with the hydroxyl oxygen atom of Tyr121. At
site II, the ammonium group interacts with the aromatic groups of Trp84, Phe330 and
Tyr334 as well as the carboxyl group of Asp72; the phenyl group interacts with the
aromatic groups of Trp84 and His440; the indanone moiety interacts with the aromatic
groups of Tyr70, Tyr334 and Trp279; the carbonyl oxygen atom forms a hydrogen bond
with the hydroxyl hydrogen atom of Tyr121 21; and the proton at the piperidine nitrogen
forms a hydrogen bond with the hydroxyl oxygen atom of Tyr121. At site HI, the
ammonium group interacts with the aromatic groups of Tyr70, Tyr121 21 and Trp279; the
phenyl group interacts with the aromatic group of Trp279; the indanone moiety interacts
with the aromatic groups Trp84, Phe330 and Tyr334; the methoxyl oxygen atom at the 6position of the indanone forms a hydrogen bond with the hydroxyl hydrogen atom of
Tyr121 and the proton at the piperidine nitrogen forms a hydrogen bond with the
hydroxyl oxygen atom of Tyr70. Site I is different from site II only in that the hydrogen
bond donor for the carbonyl oxygen atom of E-2020 is the amide hydrogen atom of
The two methoxy
Phe288 at site I and the hydroxyl hydrogen atom of Tyr121 atII.
site
groups of (R)-E-2020 are exposed to the solvent at sites I and II.
Similar to the (R)-E-2020, (S)-E-2020 possesses three overlapping binding sites,
two of which (I and II) are more favorable than site III and at each site it spans the whole
gorge. At site I, the ammonium group interacts with the aromatic groups of Trp84 and
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Phe330 as well as the carboxyl group of Asp72; the phenyl group interacts with the
aromatic groups of Trp84, Phe330 and His440; the indanone moiety interacts with the
aromatic groups of Tyr70, Tyr121, Tyr334 and Trp279; the carbonyl oxygen atom forms
a hydrogen bond with the amide hydrogen atom of Phe288; and the proton at the
piperidine nitrogen forms a hydrogen bond with the hydroxyl oxygen atom of Tyr121. At
site II, the ammonium group interacts with the aromatic groups of Trp84, Phe330 and
Tyr334 as well as the carboxyl group of Asp72; the phenyl group interacts with the
aromatic groups of Trp84, Phe330, Tyr334 and His440; the indanone moiety interacts
with the aromatic groups of Tyr70, Tyr334 and Trp279; the carbonyl oxygen atom forms
a hydrogen bond with the hydroxyl hydrogen atom of Tyr121; and the proton at the
piperidine nitrogen forms a hydrogen bond with the hydroxyl oxygen atom of Tyr121. At
site III, the ammonium group interacts with the aromatic groups of Tyr70 and Trp279; the
phenyl group interacts with the aromatic groups of Tyr70 and Trp279; the indanone
moiety interacts with the aromatic groups of Trp84, Phe330, Tyr334 and His440; the
methoxyl oxygen atom at the 6-position of the indanone forms a hydrogen bond with the
amide hydrogen atom of Gly119; and the proton at the piperidine nitrogen forms a
hydrogen bond with the hydroxyl oxygen atom of Tyr70. Similar to (R)-E-2020, site 1 is
different from site II only in that the hydrogen bond donor for the carbonyl oxygen atom
of E-2020 is the amide hydrogen atom of Phe288 at site I and the hydroxyl hydrogen
atom of Tyr121 at site II. The two methoxyl groups of the (S)-isomer are also exposed to
the solvent at sites I and II. The authors concluded that sites 1 and II are the binding sites
for both isomers of E-2020 with site III considered as an 'unlikely' one. They could not
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though specify which site, I or II, is preferred for E-2020. Available structure - activity
data support the availability of both sites I and II to E-2020.
The results of the docking analysis of Pang et al. (Pang et al., 1994b) are
supported by the findings of the study of Villalobos et al. (Villalobos et al., 1994).
Villalobos et al. report on the synthesis, structure-activity relationships and possible mode
of binding of a series of N-benzylpiperidine benzisoxazoles and related derivatives,
compounds that incorporate bioisosteric replacements for the benzoyl moiety and are
devoid of chiral centers that could undergo facile racemization. Their modeling strategy
consisted of an initial manual docking of a benzisoxazole inhibitor within the gorge by
locating possible salt bridge and hydrogen -bonding sites on the protein that could
complement those found on the inhibitor. Asp72 was the only accessible negatively
charged amino acid and the inhibitor was placed in the gorge with the piperidine N-H
oriented in a roughly perpendicular fashion to the plane defined by the carbox.ylate group
of Asp72 and was consistent with the results of the study of Pang et al. (Pang et al.,
1994b) for E-2020. Then, extended molecular dynamics calculations were performed on
this system with explicit solvent. Their results indicate the presence of hydrogen bond
between the positively charged piperidine and the carboxylate side chain of Asp72, 90%
of the time, between the benzisoxazole oxygen and the backbone of Phe288, 93% of
the time. The N-benzyl substituent forms an off-center π - stacking interaction with the
indole side chain of Trp84 with a distance near the minimum reported for a planar πstacked interaction between two benzene rings in the gas phase. The phenyl ring of

53

Phe330 interacts with the phenyl ring of the benzisoxazole inhibitor and the indole chain
of Trp279 forms an edge - to - face contact pair with the benzisoxazole.
Two putative binding sites for THA and other reversible acetylcholinesterase
inhibitors in the three dimensional structure of Torpedo Californica AChE, one being the
catalytic site and the other near the residues Trp279, Tyr70 and Phe290 were previously
identified. The latter constitutes the so called pheripheral site, located at the opening of
the enzymatic binding pocket, far from the catalytic site at the bottom of the gorge. The
catalytic site has been shown by x-ray crystallography to bind THA but no TI-IA was
found in the pheripheral site. The peripheral site is absent from mammalian
butyrylcholinesterase. Based on the presence of these two binding sites, a series of
alkylene linked bis-THA and alkylene linked benzyl-THA analogs were developed (Pang
et al., 1996). The alkylene linked bis-THA analogs were up to 10000-fold more selective
and 1000-fold more potent than THA in inhibiting rat AChE and yet they required one
simple reaction to synthesize. The best chain length for the bis-THA analogs was
determined experimentally to be 7 methylene groups between the two THA's. A spacing
of 7 methylene units was found to be optimal in the case of the alkylene linked benzylTHA analogs which were though less potent than the bis-THA analogs. The results of
that study demonstrate the powerful capabilities provided by the combination of docking
analysis with structure - activity data in the rational drug design process.
Yamamoto et al. performed a docking analysis of a series of benzylamino
acetylcholinesterase inhibitors with a phthalimide, benzoyl or indanone moiety
(Yamamoto et al., 1994). Since there is no available three dimensional structure for the

human AChE, based on its high amino acid sequence homology with the Torpedo
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Californica AChE which was recently crystallized, and due to the fact that the residues
constituting the surface of the ligand - binding, pocket are identical in the two
acetylcholinesterases except for Phe330 which is replaced with Tyr in the Human
enzyme, they replaced Phe330 by Tyr with the identical conformation in the Torpedo
AChE and used that as a model for the Human AChE in their docking studies. The
program DOCK developed by one of the authors was employed in the their docking
analysis. DOCK represents the negative image of the binding site as a cluster of spheres
and docks the ligand molecule by a distance - matching algorithm. A modified version of
DOCK, directed - DOCK combined with a systematic conformational search for docking
flexible ligands was also used. Their results, concerning the behavior of more than 50
compounds, are consistent with the structure - activity data available for the compounds
considered and seem to implicate the same amino acid residues recorded in the docking
studies discussed above, in similar modes of interactions with the ligands. Specifically,
Trp84 and Trp279, located at the bottom of the binding cavity and at the peripheral
hydrophobic site, respectively, are observed to interact with the aromatic groups of the
reversible inhibitors while the hydrogen bonding interactions of the hydroxyl group of the
side chain of Tyr121 with the C = O group(s) of the ligand are proven to be significant for
tight binding.
Recently, Inoue et al., performed a docking study of E-2020 and two of its
analogs that differ in the length of the alkylene chain linking the indanone and the
piperidine moieties (Inoue et al., 1996). The interactions of these compounds with both
the free and the acylated Torpedo Californica AChE enzyme were studied using the
available three-dimensional structure for Torpedo AChE and a Monte Carlo - based
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stochastic docking algorithm developed in-house. Their docking strategy involved a
series of operations consisted of mapping the receptor in a grid - point fashion according
to van der Waals, electrostatic and hydrogen bonding potential characteristics of the
atoms of the active site gorge, generating plausible initial binding-site coordinate sets on
the basis of hydrogen bonding between donor - acceptor heteroatom. pairs of the inhibitor
and the active site gorge of the receptor, initial docking alignments based on steric and
charge complementarity and Monte Carlo sampling to establish intermolecular lowenergy alignments. Five types of key binding interactions were identified namely the
interaction between the indanone ring and the indole chain of Trp279, the interaction
between the methoxy group of the indanone ring and the main chain carbonyl of Arg289,
the interaction between the carbonyl group in the indanone ring and the hydroxy group of
Tyr121 or Tyr70, the interaction between the NH group in the protonated piperidine and
the carboxyl group of Asp72, the phenyl ring of Phe330 or the hydroxy group of Tyr121
and the interaction between the phenyl ring of the benzyl piperidine and the indole ring of
Trp84. The presence of these binding interactions was evaluated in all the models
obtained through the docking strategy described. In general, all of the docking models
have the benzyl group at the bottom of the active-site cavity and the indanone ring
located at the entrance to the cavity, as realized in previously conducted docking studies.
Since the crystal structure for Torpedo Californica ACNE became available
recently, the number of docking studies concerning reversible acetylcholinesterase
inhibition is limited, yet characterized by a wealth of information which along with
structure - activity data has already led to the design of new more effective and selective
potential treatments of Alzheimer's type senile dementia.
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However, none of the currently existing studies in the literature considers an
integrated picture of the human receptor in the form of some molecular - modeling
methodology derived three-dimensional model in the absence of the more realistic image
provided by crystallography.
The present study consists of an extensive series of docking simulations combined
with structural analysis performed in an attempt to identify the modes of interactions of
three potent reversible acetylcholinesterase inhibitors, for which biological activity data
are available in the literature, with the amino acid residues located in the binding cavity
confined by the active site gorge of the Human acetylcholinesterase considering for the
first time a full three dimensional homology-based model for the human enzyme.

4.2 Methodology
Three analogs of the indanone-benzylpiperidine reversible acetylcholinesterase inhibitors
were considered in the present study (Figure 15). These are compounds 2, 11

and 12 from

the conformational analysis and molecular-shape comparison work of Cardozo et al.
(Cardozo et al., 1992b).
The initial conformations for the three inhibitors were constructed using the
available chemical fragments in SYBYL 6.2. The structures thus obtained were energy
minimized with MAXIMIN2 in SYBYL 6.2 using the TRIPOS force field and their
geometries were subsequently subjected to full optimization using MOPAC 6.0. The
MNDO partial charges of the atoms of the optimized geometries were also calculated
with MOPAC 6.0 within SYBYL 6.2.
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Only the amino acid residues constituting the active site gorge of the human
acetylcholinesterase with the added polar hydrogens were used as the receptor in this
docking study. The corresponding residues were extracted from the three dimensional
homology-based model of the human acetylcholinesterase derived as described in 2.3 and
Kollman charges were assigned to the atoms of the receptor.
The docking searches were performed using AutoDock 2.4 (Morris et al., 1996).
AutoDock uses a Monte Carlo simulated annealing technique for configurational
exploration with a rapid energy evaluation using grid based molecular affinity potential
combining the advantages of a large search space and a robust energy evaluation. The
energy calculations allow the inclusion of van der Waals, electrostatics and hydrogen
bonding interactions. The potential parameters provided with the program were used in
this study with a sigmoidal distance-dependent dielectric function to model solvent
screening. The grids of affinity potentials were calculated on a volume of 20x20x20
and centered on the center of the receptor; the spacing between the grid points was 0.4

.

The extensive docking searches performed in this study involved 100 "jobs" for
each one of the three considered reversible inhibitors. Each "job" consisted of 10
independent runs, each of which begins with the same initial conditions. A run was a
sequence of 50 constant temperature annealing cycles each with a maximum of 30,000
steps rejected or 30,000 steps accepted. Each "job" was seeded with a time-dependent
random number generator seed.
During each constant temperature cycle, random changes are made to the ligand's
current position, orientation and conformation. The resulting new state is then compared
to its predecessor; if the new energy is lower than the last, this new state is accepted. I f
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the new state's energy is higher than the last, this state is accepted probabilistically. The
probability depends on the energy and cycle temperature.
An initial annealing temperature of 400 kcal/mol (RT in the Boltzmann factor)
with a temperature reduction factor of 0.9 to avoid trapping the system in local energy
minima.
Full flexibility of the ligands was allowed with a dihedral step of 1 ° while the
maximum step sizes used for the ligands were 0.1

for translation and 1 ° for rotation.

AutoDock 2.4 consists of mainly three modules that accomplish the tasks of the
preparation of the receptor in PDB-like file format, the preparation of the ligand
identifying its rotatable bonds, the construction of the grids of the molecular affinity
potentials and the actual docking searches.
During the course of this study, we developed an environment for the systematic
performance and rapid and efficient evaluation, analysis and visualization of the docking
calculations from AutoDock 2.4. This 'Automated Docking Environment' (ADE) was
developed to minimize user interaction and consists of a series of FORTRAN and Sybyl
Programming Language (SPL) codes and UNIX scripts assisting many of the tasks
involved in initializing and analyzing automated docking calculations. ADE could
therefore be easily applied in database screening for identifying potential leads.
Our docking approach consisted of selecting the lowest energy conformation from
each one of the 100 docking 'jobs' for each of the inhibitors studied. The resulting 100
conformations for each ligand were subsequently visualized in SYBYL 6.2 as part of the
ADE application. The selected 100 conformations of each inhibitor were categorized
according to their geometric (torsional angles) and topologic (docking location within the
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receptor) characteristics into 'patterns'. The lowest energy representative of each 'pattern'
was then used and the geometry of its complex with the full three dimensional model of
the Human AChE was optimized with MAXIMIN2 using the Tripos force field to a
gradient of 0.5 kcal mol d A The energies of the resulting complexes were recorded and
.

their structural features analyzed according to five key interactions of the ligand with the
surrounding amino acid residues of the receptor.

4.3 Results
The five key interactions of the ligands with the amino acid residues of the active site
gorge of Human AChE considered were: (K11) the interactions of the carbonyl oxygen of
the indanone ring, (K2) the interactions of the piperidine nitrogen, (K13) the interactions
of the indanone ring with the aromatic groups of the surrounding amino acid residues,
(K14) the interaction of the piperidine ring with the surrounding aromatic groups and
(Kb) the interactions of the methyl substituent of the piperidine nitrogen with the
surrounding aromatic groups.
For Analog 1, twelve different patterns were initially identified. One of the
identified patterns was though engaged in serious steric overlaps with the surrounding
amino acid residues of the active site of Human AChE which were unable to be overcome
and was therefore disregarded. The remaining patterns, indicated as Pattern A to Pattern
K, the percentage of the conformations belonging to each pattern with the energy of the
pattern's lowest energy representative and the energy of its minimized complex with the
human enzyme are given in Table 12. The optimized geometries of the complexes of the
identified patterns with Human AChE are displayed in Figure 28.
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For Analog 2, thirteen patterns were identified indicated as Pattern A to Pattern
M, shown in Figure 29, and for Analog 3, twelve patterns were identified indicated as
Pattern A to Pattern K, which are given in Figure 30. Tables 13 and 14 contain the
percentage of conformations in each pattern, the lowest energy in each pattern and the
energy of the minimized complexes for Analog 2 and Analog 3 respectively.
The analysis of the optimized geometries of the complexes of Human AChE with
the large number of identified patterns for the three ligands studied, resulted in a wealth
of structural information regarding the five key interactions of the three reversible
inhibitors described above with the surrounding amino acid residues of Human AChE.
This information has been summarized in Tables 15-19.
The first and most gratifying observation is the excellent prediction of the
potencies of the three analogs considered by the automated docking calculations. Indeed,
as can be seen in Tables 12 -14, the total binding energies calculated with AutoDock 2.4
for all the identified patterns of Analog 1, the least potent analog, are the highest of all the
three analogs. The corresponding total binding energies for all the patterns of Analog 2
are the lowest, in agreement with the analog's highest inhibitory activity.
The most stable pattern for Analog I, as predicted by AutoDock 2.4, is Pattern F,
with -37.61 kcal/mol, for Analog 2, Pattern D was the most stable with a total binding
energy of -48.72 kcal/mol and for Analog 3, Pattern E, the lowest energy one, has a total
binding energy of -44.08 kcal/mol. Therefore, the rank in energy, El >E3>E2 matches the
rank in potency, Analog I < Analog 3 < Analog 2.
Automated docking calculations can therefore, in spite of their inherent simplicity
in the consideration of the ligand-receptor interactions, successfully predict the binding
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affinity of a series of ligands for a particular enzyme. This is particularly important when
combined with the ease the developed Automated Docking Environment offers to
perform database screening for potential new leads.
The calculated binding energies of the optimized geometries of the patterns of all
the ligands with the human enzyme though, were not as exciting. In this case, Pattern H is
the most stable one for Analog 1 with a total binding energy of - 5,718.623 kcal/mol,
Pattern K had the lowest energy among the patterns of Analog 2 with a total binding
energy of -5,729.222 kcal/mol and for Analog 3, Pattern D was the most stable with a
binding energy of -5,737.691 kcal/mol.
Therefore, in the case of the binding energies of the optimized structures of the
complexes, the order is E3<E2<E1 instead of the expected E2<E3<E1.
For Analog 1, Patterns F and H, the former being the most stable according to
AutoDock binding energy calculations and the latter according to the energy of the
optimized complex geometry, appear to be located in a completely opposite way in the
active site of Human AChE (Figure 31). In Pattern H, the indanone and piperidine rings
are perpendicular to each other as has been confirmed and observed before (Cardozo et
al., 1992b, Inoue et al., 1996). This is not the case for Pattern F. In Pattern H, the
indanone ring is parallel to the indole side chain of Trp117 (Trp 84 in Torpedo AChE).
This mode of interaction has been observed before as constituting a high energy
conformer for E-2020 (Inoue et al., 1996). Pattern F, has the piperidine ring located in the
bottom of the active site gorge of Human AChE. This mode of interaction has been
identified previously (see for example Inoue et al., 1996) as being the most prevalent.
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For Analog 2, Patterns D and K, the former the AutoDock minimum energy and
the latter the minimum energy optimized complex, exhibit the same basic characteristics,
both having the indanone ring and the piperidine ring perpendicular to each other (Figure
32). They also resemble Pattern H of Analog 1. In both patterns, the indanone ring points
towards the bottom of the active site gorge. This has been identified as a high energy
interaction for indanone-piperidine analogs (Inoue et al., 1996). In Pattern D, the
indanone ring is found perpendicularly located with respect to Trp 117, similarly to
Pattern H of Analog I.
Finally, in Analog 3, Pattern D was the minimum energy one for the optimized
complex and Pattern F the most stable as predicted by AutoDock 2.4. Both patterns have
their indanone rings perpendicular to their indanone rings (Figure 33). Their piperidine
rings are also located in the bottom of the active site gorge of the enzyme. This, as
mentioned above, has been recognized as the most common and most likely binding
mode for indanone-piperidine compounds (Inoue et al., 1996, among others). In both
patterns, the indanone ring is also perpendicular to the indole side chain of Trpl 17, as
was previously observed for similar compounds (Inoue et al., 1996).
A further thermodynamic analysis is necessary to be used along with the results of
this study. These kind of calculations are very computationally intensive since they
involve extensive molecular dynamics simulations for configurational sampling and
estimation of free Gibbs energy values. Solvation energy calculations and in particular
calculations of the electrostatic contribution in the binding energies are currently under
way. These calculations generally require fewer computer resources and have been
successfully employed in the prediction of the binding affinities of various ligands to
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their receptors leading to very good agreement with experimental data (for Torpedo

Californica AChE, see Wiodek et al., 1996).

CHAPTER 5
CONCLUSIONS AND RECOMMENDATIONS FOR FUTURE WORK
The controversial role of the electrostatic interactions in the process of steering of
acetylcholine into the active site of acetylcholinesterases was investigated in the present
study.
For the purpose of the simulation of the process of recognition of acetylcholine by
wild type and charge neutralized mutated Human acetylcholinesterases, the three
dimensional, homology-based models of the two enzymes were developed using the
existing crystal structure of Torpedo Californica acetylcholinesterase as a template.
A novel methodology was designed and implemented to simulate the process of

steering of the ligand into the active site of the studied enzymes. The obtained results
suggest that the electrostatic field affects the steering of the ligand only when it is in close
proximity to the entrance of the active site gorge of the enzymes. The steering process
maybe diffusion-controlled when the ligand is further away from the surface of the
enzymes. The electrostatic energy was the predominant form of energy of the complexes
of acetylcholine with the studied acetylcholinesterases. The charge neutralized mutated
Human acetylcholinesterase appeared to retain 35% of the electrostatic field of the
negatively charged wild type Human acetylcholinesterase.
Three irreversible acetylcholinesterase inhibitors were also subjected to the
methodology employed for the natural substrate acetylcholine. Their behavior in the
steering process is in excellent agreement with the above mentioned findings pertaining
to acetylcholine.
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The global minimum of the studied complexes was consistently located in wild
type Torpedo Californica and Human acetylcholinesterases. The organophosphate DFP
was the only exception to that observation. A further investigation of this phenomenon
and its link to the potency of inhibition of DFP is necessary. The correlation of the
location of the global energy minimum and the diffusion-electrostatics border with
inhibitory potency should also be further examined.
A number of transition states was also revealed by the simulation of the steering
process. The role of the identified transition states should also be elucidated.
The covalent adducts of Torpedo Californica and Human AChE's with selected
organophosphate inhibitors were modeled and subjected to structural analysis. A novel
methodology was designed and implemented to perform the modeling of the covalent
complexes. This methodology can be applied to other covalent docking problems.
The simulations predict the stereoselectivity of Human AChE but not of Torpedo
AChE towards Sarin PS inhibitor. The aging predictions were though in conflict with
previous observations.
The observed hydrophobic interactions of the organophosphate moieties with the
surrounding aromatic amino acid residues of the active site of the enzymes were in very
good agreement with the ones reported in the literature. A new mode of hydrophobic
interaction of the organophosphate moiety with Trp233 (Trp267 in Human AChE) was
identified in this study. The organophosphate moieties interact with the aromatic side
chain of Trp84 in Torpedo but not with the homologous Trp 1 17 residue of Human ACNE.
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The Oy atom of the active site serine in all the complexes modeled was hydrogenbonded to Ala201 (Ala235 in Human) and the phosphonyl oxygen to Gly119 (G1)7153 in

Human). The close contacts of the phosphonyl oxygen with Gly118 (Gly152 in Human)
and. Ala201 (Ala235 in Human) were also successfully reproduced.
The proximity of Glu199 (Glu233 in Human), previously suggested as
contributing to the charge stabilization of the leaving carbocation during the aging
process, to the alkyl groups of the organophosphate moieties was not observed.
The organophosphate structural characteristics identified in the present study can
be used for the design of more potent and selective irreversible acetylcholinesterase
inhibitors.
The last part of this study involved a very extensive docking analysis for the
prediction of the binding sites and bioactive conformations, in. Human AChE, of three
reversible acetylcholinesterase inhibitors, belonging to the family of indanone-piperidine
compounds, clinically investigated for the treatment of Alzheimer's type senile dementia.
An Automated. Docking Environment and Methodology was developed based on
AutoDock 2.4 to perform the docking simulations.
A wealth of structural information for the interactions of key chemical groups on
the studied inhibitor analogs with the amino acid residues within the active site of Human
AChE was obtained from the docking calculations. The simulations successfully
reproduced the inhibitory activity of the studied analogs and the binding modes observed
for structurally similar compounds in Torpedo AChE.
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Molecular dynamics calculations coupled to automated docking and explicit
solvent simulations are necessary to more accurately represent the binding environment
of the studied analogs in Human AChE.
The Automated Environment and Methodology developed during the course of
this study, can be directly applied to fastly screen drug databases for the identification of
new lead compounds and predict their inhibitory potentials.

APPENDIX A
TABLES
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Table 1. Variation of the total, electrostatic, 1-4 electrostatic and van der Waals energy
values (in kcal/mol) of the Torpedo AChE-ACh complex relative to the global energy
minimum with the distance (in ) of the center of mass of ACh from the C α atom of the
Ser200 residue of the active site of Torpedo ACNE.
Distance

5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
74
25
26
27
28
29
30
31
32
3 198.43 205.324 -2.30 31.924

Total Energy

Electrostatic
Enemy

158.357
155.695
153.288
147.754
145.669
140.661
152.341
122.832
143.788
62.441
94.034
0.000
118.473
128.155
130.698
147.897
148.514
165.768
179.597
189.717
190.783
192.373
194.489
195.631
196.966
195.517
196.501
198.201

165.551
165.542
160.990
159.827
161.135
157.191
170.996
150.221
145.881
61.872
96.661
0.000
112.020
122.891
133.947
148.758
148.508
177.839
195.166
202.743
202.233
201.659
204.058
204.367
204.446
202.593
203.601
205.113

Electrostatic van der Waals
Enemy 1-4
Energy
-2.456
1.514
1.501
-0.233
-2.586
-3.749
-3.986
-4.744
-4.413
-9.096
-10.954
0.000
0.233
-1.644
-2.533
-1.333
-1.667
-5.723
-4.307
-2.300
-2.266
-2.263
-2.283
-2.283
-2.291
-2.299
-2.294
-2.301

12.797
12.781
14.275
12.153
10.360
7.475
9.339
-0.565
6.403
0.109
2.270
0.000
10.989
16.564
16.137
20.997
22.335
20.122
21.217
25.706
27.312
29.482
29.259
30.073
31.336
31.747
31.716
31.900
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Table 2. Variation of the total, electrostatic, 1-4 electrostatic and van der Waals energy
values (in kcal/mol) of the Human AChE-ACh complex relative to the global energy
minimum with the distance (in ) of the center of mass of ACh from the C α atom of the
Ser234 residue of the active site of Human AChE.

Distance

5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35

Total Energy

42.878
38.939
1166.671
23.586
1070.608
999.984
45.823
57.056
46.512
37.400
31.755
61.823
0.000
53.188
49.410
34.734
72.747
74.336
82.564
91.683
92.019
92.218
94.070
94.872
95.746
96.364
97.079
98.542
99.234
99.334
99.505

Electrostatic
Energy
35.457
38.585
-42.932
12.860
45.744
-37.042
34.420
41.024
37.386
30.592
20.658
55.955
0.000
49.781
46.343
35.752
71.179
71.765
83.077
95.192
93.248
93.889
92.876
93.246
93.865
94.315
94.930
96.293
97.020
97.077
97.223

Electrostatic van der Waals
Energy
Energy 1-4
8.899
6.317
17.237
8.281
4.018
12.620
3.632
6.826
4.832
7.196
8.613
3.675
0.000
2.290
3.916
3.777
2.326
-0.551
-0.690
-2.919
-2.698
-2.669
-2.679
-2.673
-2.676
-2.674
-2.678
-2.678
-2.680
-2.680
-2.681

5.102
0.717
422.641
-2.096
373.961
370.693
8.355
7.225
10.181
3.243
5.344
7.965
0.000
8.788
10.952
7.858
13.150
16.432
15.801
15.112
17.171
16.705
19.608
20.035
20.289
20.452
20.552
20.646
20.612
20.654
20.678
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Table 3. Variation of the total, electrostatic, 1-4 electrostatic and van der Waals energy
values (in kcal/mol) of the mutated Human AChE-ACh complex relative to the global
energy minimum with the distance (in ) of the center of mass of ACh from the C α atom
of the Ser234 residue of the active site of muated Human AChE.
Distance

5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36

Total Energy

112.992
57.899
1311.024
81.529
1845.454
0.000
1167.597
39.579
114.672
44.987
42.965
8.490
12.977
111.209
151.426
170.820
165.244
174.604
174.109
174.323
173.988
174.738
176.372
177.166
177.210
176.972
177.664
178.354
178.675
178.787
178.838
178.875

Electrostatic
Energy
86.195
51.105
105.187
78.111
85.951
0.000
45.310
46.185
122.427
58.273
52.871
18.212
20.602
125.116
162.824
173.604
172.176
183.856
182.833
182.431
181.460
180.549
180.925
181.331
179.654
179.815
179.972
180.326
180.517
180.552
180.582
180.606

Electrostatic van der Waals
Energy
Energy 1-4
-1.921
-1.471
-3.864
0.819
-2.947
0.000
-3.876
-4.611
-11.077
-5.787
-5.269
-4.466
-2.159
-9.541
-14.526
-16.209
-16.321
-16.024
-16.015
-16.011
-16.028
-16.037
-16.045
-16.041
-16.056
-16.052
-16.054
-16.057
-16.059
-16.059
-16.059
-16.060

11.717
0.147
425.021
3.055
609.846
0.000
410.875
-1.013
4.223
-2.706
-2.400
-2.585
-4.005
2.875
9.740
19.706
17.210
16.809
17.441
18.072
18.746
20.413
21.671
22.059
23.774
23.368
23.905
24.245
24.373
24.452
24.472
24.485
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Table 4. Observed interactions of various organophosphate inhibitors with neighboring

amino acid residues in the acetylcholinesterase-organophospates adducts studied.
Adduct

Alkylated

y Oxygen

Oxygen

Phosphonyl

Alkyl Groups

Oxygen

H440/c 2.70
Torpedo-Sarin R

A201/a b 1.69

G118/a 2.75
G119/a b l.58
A201/a 2.97

W84,233
F288,290,331

H440/c 2.93

A201/a b 1.70
H440/c 3.18

G118/a 3.52
G119/a b 1.61
A201/a 2.92

W84,233
F288,290,331

A201/a b 1.66
H440/c 3.54

G118/a 2.64
G119/a b 1.60
A201/a 3.16

E199/d 3.53
W233,H440
F288,290,331

H478/c 2.69

A235/a b 1.66
H478/c 3.35

G152/a 3.08
G153/a b 1.64
A235/a 3.15

W267
F326,328,369

H478/c 3.41

A235/a b 1.72

G152/a 3.88
G153/a b l.59
A235/a 3.13

W267
H478
F326,328,369

H478/c 2.88

A235/a b 1.70
H478/c 3.28

G152/a 3.02
G153/a b 1.59
A235/a 3.07

E233/d 3.95 A
W267,H478
F326,328,369

Torpedo-Sarin S

H440/c 3.01
Torpedo-D FP

Human-Sarin R

Human-Sarin S

I-Iuman-DFP

Notations: a interaction with amide hydrogen, b hydrogen bond interaction, c interaction
with Nε2 of His, d interaction with oxygens of Glu sidechains.
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Table 5. Variation of the total, electrostatic, 1-4 electrostatic and van der Waals energy
values (in kcal /viol) of the Torpedo Californica AChE-Sarin PR complex relative to the
global energy minimum with the distance (in ) of the center of mass of Sarin PR from
the C α atom of the Ser200 residue of the active site of Torpedo ACNE.
Distance
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35

Total Energy
31.281
29.373
24.257
23.919
26.054
19.861
17.179
21.184
35.020
18.525
32.685
1406.858
10.062
0.000
32.527
30.554
20.163
53.443
25.002
56.099
57.520
58.815
59.201
58.653
59.272
59.006
59.232
59.999
60.103
60.103
60.103

Electrostatic
Energy
32.442
33.004
32.531
27.645
31.105
29.310
22.371
16.603
28.762
17.808
29.001
8.182
-2.093
0.000
24.278
26.325
26.799
58.527
30.755
61.744
62.281
62.412
62.010
60.983
61.193
60.921
61.098
61.813
61.913
61.913
61.913

Electrostatic van der Waais
Energy
Energy 1-4
0.194
0.800
-2.140
-3.020
-2.636
-2.869
-7.570
-7722
-2)91
-1.695
-0.798
-8.937
0.501
0.000
-l.745
-2.173
-1.632
-2.221
-2.909
-2.502
-2.520
-2.530
-2.542
-2.585
-2.574
-2.584
-2.578
-2.579
-2.575
-2.575
-2.575

2.915
-0.635
-1.326
2.650
1.000
0.560
0.809
3.948
4.950
1.827
3.962
567.667
1.791
0.000
5.095
5.073
1.480
7.040
6.629
10.358
11.257
12.458
13.259
13.773
14.142
14.174
14.220
14.265
14.268
14.268
14.268

Å
74

Table 6. Variation of the total, electrostatic , 1-4 electrostatic and van der Waals energy
values (in kcal/mol) of the Torpedo Californica AChE-Sarin PS complex relative to the
global energy minimum with the distance (in ) of the center of mass of Sarin PS from
the C α atom of the Ser200 residue of the active site of Torpedo AChE.
.

Distance

5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35

Total Energy

74.899
83.171
80.210
85.832
85.956
69.456
75.283
71.703
67.361
68.017
75.667
93.752
0.000
86.675
86.821
88.272
88.251
108.917
104.355
106.016
108.081
109.125
118.087
109.852
111.389
110.816
110.815
111.512
111.637
111.637
111.637

Electrostatic
Energy
80.532
89.627
88.036
87.812
83.817
81.735
85.006
81.129
68.218
68.569
74.522
78.421
0.000
73.851
83.717
80.773
90.293
118.714
113.527
113.574
114.081
114.285
114.372
113.991
115.172
114.328
114.290
114.935
115.063
115.063
115.063

Electrostatic van der Waals
Energy
Energy 1-4
l.298
2.770
4.263
2.284
3.286
2.691
2.527
2.657
3.631
3.289
2.332
1.761
0.000
5.266
5.257
2.742
3.427
2.946
2.645
2.539
2.502
2.488
2.455
2.444
2.403
7.385
2.398
7.383
2.388
2.388
2.388

7.183
7.682
5.826
11.368
12.994
4.824
6.041
5.701
4.685
7.268
9.452
10.334
0.000
15.884
13.050
18.032
12.832
14.013
15.842
17.722
19.363
20.233
21.156
21.339
21.714
21.999
22.031
22.083
22.086
22.086
22.086

Å
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Table 7. Variation of the total, electrostatic, 1-4 electrostatic and van der Waals energy
values (in kcal/mol) of the Torpedo Californica AChE-DFP complex relative to the
global energy minimum with the distance (in ) of the center of mass of DR' from the
C α atom of the Ser200 residue of the active site of Torpedo ACNE.

Distance
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34

Total Energy
7.150
26.145
27.859
18.591
21.760
24.671
0.000
8.407
32.523
20.631
1003.948
28.182
12.672
37.376
17.727
24.854
18.345
17.667
51.885
50.018
54.783
55.530
55.906
55.602
55.559
54.482
56.433
56.455
56.581
56.581

Electrostatic
-17.999
14.186
16.224
12.087
11.306
15.454
0.000
-1.887
-51.584
5.070
-6.855
-0.077
-8.492
8.255
1.663
11.624
8.228
11.678
46.354
44.715
47.322
46.479
46.316
45.665
45.423
44.291
46.133
46.149
46.266
46.266

Electrostatic van der Waals
Energy Energy 1-4 Energy
6.661
3.432
0.336
-1.237
-2.153
-0.655
0.000
-1.821
5.277
-2.470
2.681
-4.748
4.894
2.122
0.377
1.629
0.046
-0.356
-0.517
-1.283
0.722
0.731
0.732
0.732
0.735
0.734
0.733
0.733
0.736
0.736

7.548
7.056
4.846
7.705
7.996
6.824
0.000
-0.053
-6.591
2.074
361.987
6.120
8.759
14.183
9.612
10.277
9.132
9.793
17.130
16.939
20.636
22.227
22.771
73.110
23.306
23.374
23.473
23.479
23.486
23.486

Å
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Table 8. Variation of the total, electrostatic, 1-4 electrostatic and van der Waals energy
values (in kcal/mol) of the Human AChE-Sarin PR complex relative to the global energy
minimum with the distance (in ) of the center of mass of Sarin PR from the C α atom of
the Ser234 residue of the active site of Human AChE.
Distance

5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33

Total Energy

Electrostatic
Energy

18.807
27.475
25.094
18.340
19.549
11.447
32.466
6.958
19.705
1y27
0.000
10.759
37.447
5.563
25.136
36.442
37.609
45.338
45.727
46.189
47.687
47.451
47.912
48.332
48.623
49.383
49.381
50.040
50.040

1.796
26.219
23.945
6.160
14.852
14.715
22.252
12.354
3.877
-1.643
0.000
15.854
38.844
10.299
26.795
39.142
41.346
51.084
50.425
50.121
49.785
49.160
49.287
49.476
49.630
50.327
50.321
50.929
50.929

Electrostatic van der Waals
Energy
Energy 1-4
8.466
4.054
-0.428
3.924
1.719
-0.794
2.638
-4.297
-l.087
-1.668
0.000
2.000
-2.682
0.789
-0.228
-2.233
-2.190
-3.349
-3.279
-3.213
-3.281
-3.249
-3.232
-3.736
-3.223
-3.226
-3.224
-3.224
-3.224

4.022
-2.182
0.690
1.638
-0.109
-3.695
-0.559
-1.519
5.526
5.904
0.000
-0.066
3.764
-1.293
2.481
5.344
4.933
6.211
7.178
8.248
10.090
10.473
10.801
11.039
11.173
11.230
11.237
11.285
11.285

Å
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Table 9. Variation of the total, electrostatic, 1-4 electrostatic and van der Waals energy
values (in kcal/mol) of the Human AChE-Sarin PS complex relative to the global energy
minimum with the distance (in ) of the center of mass of Sarin PS from the C α atom of
the Ser234 residue of the active site of Human ACNE.

Distance

5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33

Total Energy

36.113
10.019
35.643
4.315
14.694
19.870
0.000
7.496
23.149
8.286
11.921
16.386
14.244
33.267
11.476
13.362
32.926
44.617
34.294
41.666
43.082
43.766
44.477
43.949
44.632
44.843
44.927
45.558
45.558

Electrostatic
Energy
33.052
6.971
21.934
-1.502
12.805
22.800
0.000
4.201
16.390
10.857
15.412
5.298
10.507
31.447
10.656
9.430
28.586
42.866
34.844
41.266
41.599
41.552
41.795
41.040
41.697
41.821
41.890
42.461
42.461

Electrostatic van der Waals
Energy
Energy 1-4
0.593
2.011
1.371
1.500
-0.032
-1.138
0.000
0.719
-3.097
-3.375
-3.157
3.501
-0.641
-3.989
0.339
0.063
-1.796
-3.128
-2.074
-2.875
-2.845
-2.844
-2.849
-2.849
-2.831
-2.842
-2.842
-2.843
-2.843

3.819
3.216
5.405
2.177
3.152
1.362
0.000
-0.721
7.698
2.951
4.835
9.720
9.085
7.372
8.003
11.159
13.519
14.002
12.569
13.781
14.896
15.613
16.093
16.323
16.341
16.435
16.449
16.508
16.508

Å
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Table 10. Variation of the total, electrostatic, 1-4 electrostatic and van der Waals energy
values (in kcal/mol) of the Human AChE-DFP complex relative to the global energy
minimum with the distance (in ) of the center of mass of DFP from the C α atom of the
Ser234 residue of the active site of Human AChE.
Distance

5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33

Total Energy

0.000
62.395
63.938
15.924
43.811
1173.214
176.092
52.295
48.450
46.886
64.420
56.716
62.827
50.695
68.347
52.727
91.345
82.507
87.640
91.873
92.776
92.992
92.108
92.239
92.697
92.685
93.086
94.119
94.119

Electrostatic
Energy
0.000
54.845
56.173
7.964
46.199
44.855
58.870
36.035
41.308
53.830
69.932
62.205
58.319
48.895
73.091
60.955
94.092
90.900
97.008
104.944
103.820
102.437
101.308
101.227
101.494
101.356
101.696
102.700
102.700

Electrostatic van der Waals
Energy
Energy 1-4
0.000
-5.713
-7.608
-3.800
-8.233
-12.885
-7.095
-3.106
-7.117
-11.080
-12.358
-7.948
-8.859
-7.419
-9.134
-8.160
-12.557
-13.167
-13.044
-15.320
-15.313
-15.309
-15.301
-15.299
-15.299
-15.302
-15.302
-15.299
-15.299

0.000
8.262
11.639
2.107
1.814
442.904
85.801
12.318
4.548
6.112
8.763
8.015
14.548
7.957
9.541
9.470
18.446
16.385
15.625
14.009
16.073
17.676
17.928
18.140
18.332
18.457
18.517
18.543
18.543

Table 11. Summary of the results of the simulation of the steering process of selected ligands and inhibitors into the active site gorge of
acetylcholinesterases from different species.

(A)

Diffusion Electrostatics
Border

Torpedo - ACh

16

(A)
24

5

Torpedo - Sarin PR

18

24

5

Torpedo - Sarin PS

17

22

Torpedo DFP

11

23

1111177077 - ACh

17

24

5

7

9

mut I I 71117C111 - ACh

10

19

5

7

9

11

13

Sarin PR

15

22

9

11

13

- Sarin PS

11

24

5

21

Complex

Human -

Human - DFP

Global Energy
Minimum Location

Transition States Locations
(A)

11

9
7

6

15

13

9
6

5

13

10

13

7

10

18

15

12

10

22

16

11

7

19

16

l.6

20

18

17
16

13
15

18
17

22
19
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Table 12. The percentage of conformations belonging to each pattern, the energy (in
kcal/mol) of each pattern's lowest energy representative and the energy (in kcal/mol) of
the complex of the lowest energy conformation of each pattern with Human AChE for
Analog 1 (IC 50 = 8.4 nM). The lowest energy pattern is highlighted in bold and italic

Pattern Percentage

Lowest Energy

Energy of Complex

A

25

-37.24

-5,653.521

B

17

-37.17

-5,643.561

C

1

-33.20

-5,654.309

D

1

-36.82

-5,655.658

E

1

-33.65

-5,676.238

F

29

-37.61

-5,665.721

G

5

-33.77

-5,649.411

H

10

-35.48

-5,718.623

I

2

-37.19

-5,666.181

J

2

-35.57

-5,648.632

K

1

-32.95

-5,661.296

8I

Table 13. The percentage of conformations belonging to each pattern, the energy (in
kcal/mol) of each pattern's lowest energy representative and the energy (in kcal/mol) of
the complex of the lowest energy conformation of each pattern with Human AChE for
Analog 2 (IC50 = 0.82 nM). The lowest energy pattern is highlighted in bold and italic.

Pattern

Percentage

Lowest Energy

Energy of Complex

A

43

-47.22

-5,663.377

B

9

-45.39

-5,654.094

C

3

-44.74

-5,681.411

D

9

-48.72

-5, 654. 852

E

13

-47.85

-5,675.134

F

6

-46.78

-5,652.158

G

3

-44.87

-5,698.812

H

7

-43.54

-5,658.358

I

1

-44.14

-5,658.850

J

3

-45.03

-5,686.708

K

1

-45.12

-5,729.222

L

1

-42.57

-5,649.637

M

1

-43.90

-5,639.814

8 2
-

Table 14. The percentage of conformations belonging to each pattern, the energy (in
kcal/mol) of each pattern's lowest energy representative and the energy (in kcal/mol) of
the complex of the lowest energy conformation of each pattern with Human AChE
for
Analog 3 (IC 50 = 3.0 nM). The lowest energy pattern is highlighted in bold and italic.

Pattern

Percentage

Lowest Energy

Energy. of Complex

A

14

-40 71

-5,676.727

B

18

-42.74

-5,671.110

C

2

-41.37

-5,664.049

D

1

-40.34

-5,737.691

E

18

-44.08

-5,671.496

F

13

-42.27

-5,662.448

G

14

-41.21

-5,691.094

H

7

-41.89

-5,721.157

I

11

-41.05

-5,679.341

J

1

-41.62

-5,690.431

K

1

-36.74

-5,661.910

Å
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Table 15. Observed interactions (distances in ) of the carbonyl oxygen atom (KU) of
the indanone ring of the three analogs studied with atoms of the surrounding amino acid
residues of Human AChE. The lowest energy pattern of each analog is highlighted.
Analog 1

Analog 2

Analog 3

(1050 --- 8.4 nM)

(1050 0.82 nM)

(IC50 3.0 nM)

A

0152/a 3.50

D105/a 3.98
S156/c 2.96

S156/c 3.50

B

G152/a 3.95

Y164/c 3.78

Y480/c 3.70

Y368/c 3.95

G152/a 3.32
S234/c 3.45

0152/0 3.68
Y164/c 3.73

G152/a 3.85

S156/b c2.27

S156/b c 2.56

Y155/c 3.95
S156/c 3.33

G157/a 4.00

0152/a 3.41
S234/c 3.44

Y164/c 3.27

Y368/c 2.50
3.53

S156/b c 2.29

G152/a 3.30
S234/c 3.21

S156/c 3.02

G151/a3.63
G152/a 2.96
Y164/c 2.81

0152/a 3.34

W117/a 3.41

Y368/c 3.90

S156/c 3.22

-

Pattern

- -

C

D

5156/c

H
Y372/c

1

J

-

3.92

L

N/A

M

N/A

N/A
N118/a 3.74

N/A

Notations: a interaction with amide hydrogen, b hydrogen bond interaction, c interaction
with hydroxyl hydrogen.

Å

A
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Table 16. Observed interactions (distances in ) of the nitrogen atom (K11) of the
piperidine ring of the three analogs studied with atoms of the surrounding amino acid
residues of Human AChE. The lowest energy pattern of each analog is highlighted.
Analog 1

Analog 2

Analog 3

(/C50 = 8.4 nM)

(1050 = 0.82 nM)

(IC50 = 3.0 11M)

A

A158/a b 1.81

0153/a 3.44

-

B

A158/a 3.13

G153/a 3.40

Al58/a 3.83

C

A158/a
3.94
A158/a 3.13

G157/a 3.97
Al58/a 3.78

G157/a 3.605

G153/a 3.40

G152/a3.71

G157/a 3.75
3.22

0151/a 3.95
A158/a 3.95
Y164/c 3.36

6153/a 3.40

G

0152/a 3.37
G153/a 3.34
S234/c 3.64

0151/a 3.94
Y164/c 3.35

0153/a 3.48

H

G153/a 3.42

G480/a 3.97

G157/a 3.61

I

-

G153/a 3.41

-

J

A158/a3.81
3.54
A152/a

G153/a 3.52

-

Pattern

D
E

F
158/a

0157/a 3.97
A158/a 3.43

G153/a 3.45 G157/a 3.24

K

M

N/A

0153/a 3.86

N/A

-

N/A

Notations: a interaction with amide hydrogen, b hydrogen bond interaction, c interaction
with hydroxyl hydrogen.
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Table 17. Observed interactions (symbols in parentheses, i.e. I perpendicular) of the
indanone ring (K13) of the three analogs studied with aromatic sidechains of the
surrounding amino acid residues of Human AChE. The lowest energy pattern of each
analog is highlighted.
Pattern

Analog 1
(IC 50 = 8.4 nM)

Analog 2

Analog 3

(IC 50 = 0.82 nM)

(IC 50 = 3.0 nM)

A

'W117, H478 (-I-)
(-I-)

B

W117 (II)

Y164

Y155, F369, Y368,
1-1478

C

H478
), Y368
(-I-(L)
F369 (L)

F369, Yl55, H478

Y155, F369, Y368,
H478

W117 (II), Y164

Y155(L) (L)F369
H478 (L)

D

W117(II)

W117 (II), H478
Y368

Y164 (L)

(L)H478,

Y155 ( 9, F369 ( L)
(L)
H478 (L)

Yl55

F

Y368, H478

Y155 (L),F328(L)
F369 ( L), 1-1478 ( L)

Y164 ((I), W117 (Ii)

G

Y164 (-1-)
Y164,

Y155 (L), F328( 1-)
F369 ( L), H478 L)

P119

(

H

I

W117 W117
(II) Y164(
Y164 ( 1-)
Y155 (L)
L), F328( L)
F369 ( L), 1-1478 ( 1-)
H478 (-1-), F369 (i)
F328 (1), Y155 (-1-)
Y368 ( L)

Y164

Y164(
L)
Yl55
, F328(L)
F369 ( L), 1 -1478 ( L)
Y480 (II), Wl17 (II)

K

M

Y164 (L)

N/A

Y164

N/A

Y164

N/A
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Table 18. Observed hydrophobic interactions (symbols in parentheses, i.e.
perpendicular) of the piperidine ring (K14) of the three analogs studied with aromatic
sidechains of the surrounding amino acid residues of Human ACNE. The lowest energy
pattern of each analog is highlighted.

Pattern

Analog 1

Analog 3

Analog 2

(IC50= 8.4 nM) (IC50= 0.82 nM) (IC50 = 3.0 mil)
A

Y164 ( 1 )

B

Y164 ( 1 ), Y150 ( 1 )

C

D

II)
Y155(L),
Y368
W117F369(L),
(II) , Y164

Yl64

Y155, F369,
H478(L)
11478

Y150 (
F

)

Y155( L), F328( L
F369(L), H478(L)

Y368, H478

Y164(L)
Y164(II),
W117(II)
H478,Y155
H478(
(L)
L)

) 11155 ( I), F369
H478
I

W117 (II)
((II)
II),

J

II)

K

Y155 (L.), F369 (L), W117 (L), Yl64 (11;
14478 ( L)

1)
Y164 ((II),
Y164
W117
( 1- )

E

G

Y480, H478
W117

Y155 ( F369 ( L),
H478 ( L)

Y368(L)

Y164 ( 1 )

W117(11)

Y155, F369,11478
Y164(L)

Y155( L), F328( L

Y368, F369, l-1478

Y155(L),F328(L)
F369(L),H478(L)

Y164(, W117 Y164(L) Y480(11),W117(

L

N/A

M

N/A

N/A
Y164(11)
Y164(11)

N/A
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Table 19. Observed hydrophobic interactions (symbols in parentheses, i.e. -Iperpendicular) of the methyl substituent of the piperidine ring (K13) of the three analogs
studied with aromatic sidechains of the surrounding amino acid residues of Human
AChE. The lowest energy pattern of each analog is highlighted.
Pattern

Analog 2

Analog 1

Analog 3

(IC50 = 8.4 nM) (1050= 0.82 nM) (1050= 3.0 nM)

F326 (II), W267(II)

AB-

F326 (II),F326
, F326
P119

C

Y480
(II)
(II)
P119 (II)
Y150(<)
Y150 (II), Y164

W267
F328

E

G

H

Y150, Y164

F326, F328

Y480 ( 3-)

Y480 09

Y150

F326 (ID, W267 (II)
F328

Y150

F326 (ID, W267 (II)
F328

W267 (II), F326 (II) Y480 Y150 (ID

F326 (II), W267F369
(II) (II)
Y155,17328
F328

1

F326 (II), W267
F328
K

F326, F369, Y155
P328(II)

L

N/A

F326 (II), W267 (
F328

Y155, F369

P119 (II)

Y164

N/A
F328(I)

M

N/A

Y480(II), H478

N/A
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Table 2Q. List of amino acid residues of the Human AChE involved in interactions with
the identified patterns of the three reversible inhibitors studied and their homologous
residues in Torpedo Californica AChE.
Torpedo Californica AChE

Human AChE

TYR 70

TYR 103

ASP 72

ASP 105

TRP

84

TRP 117

GLY 119

GLY 153

TYR 121

TYR 155

SER 122

SER 156

SER 124

ALA 158

TYR 130

TYR 164

GLU 199

GLU 233

TRP 279

TRP 317

SER 286

SER 324

PHE 288

PHE 326

ARG 289

ARG 327

PHE 290

PHE 328

PHE 330

TYR 368

PHE 331

PHE 369

TYR 334

TYR 372

GLY 335

GLY Y 373

APPENDIX B
FIGURES
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muscle

Figure 1. Schematic of the neuromuscular junction. Acetylcholinesterase is located in the synaptic cleft
(after http://chemccal0.ucsd.edu/~chem215/lectures/lecture5/lecture5/node28.html).

nicotinic Ach
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v esic l e

neuron

ten-

CO =VD

Figure 2. Mechanism of hydrolysis of acetylcholine into acetate and choline by acetcholinestcrase,
The members of the catalytic triad, Sex, His and Gin, are shown alone with the three steps
of the catalytic reaction (after http://cmcind.far.ruu.nl/schel/report/H2.html),

Trigonal c complex 1

Tetrahedral comp

-Alen

Figure 3. Space—fill model of the crystal structure of Torpedo Californica Acetylcholinesterase
(after gopher://pdb.pdb.bnl.gov:70/I9/PDB/Entries/.1acylacj.gif).
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Figure 4. Alignment of the amino acid sequences of Torpedo Californica (aces_torca) and Human (aces_human) AChE's.
Identical and similar amino acids are highlighted black and gray respectively. The calculated percent similarity
is 62.63 and the percent identity is 54.10.

ace s_torca YLIF
aces_humnQPDH

ace s_t or ca
ace s_human

ace s_torca
aces human

ace s_torca
ace s_human

ace s_torca
aces human
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ace s_human

ace s_torca
ace s_human

ace s_torca
ace s_human

ace s_torca
aces_humn

ace s_t area
ace s_human

ace s_tor ca
ace s_human

Figure 5. Superposition of the structures of Torpedo California (grey) and Human (blue) AChE's with respect to the Ca atoms of their
backbones (rms deviation 0.827 Angs.). The catalytic triads of the enzymes are displayed in ball—and—stick mode.

Figure 6. Alignment of the amino acid sequences of Torpedo Californica (aces Lorca) and charge neutralized Human
(aces_mut_human) AChE' s. Identical and similar amino acids are highlighted black and grey respectively.
The calculated percent similarity is 62.12 and the percent identity is 53.75.
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Figure 7. Superposition of the structures of Torpedo Californica (grey) and charge neutralized mutated Human (blue) AChE's with respect to the Ca
atoms of their backbones (rms deviation 0.865 Angs.). The catalytic triads of the enzymes are displayed in ball—and—stick mode.

Figure 8. Superposition of the structures of Human (grey) and charge neutralized mutated Human (blue) AChE's with respect to the Ca atoms
of their backbones (rms deviation 0.672 Angs.). The catalytic triads of the enzymes are displayed in ball—and—stick mode.

in red.

Figure 9. Calculated electrostatic potential map around acetylcholine. The +1 contour is displayed

z

00

Figure 10. Three dimensional model of Torpedo Californica AChE. The blue, red and yellow ribbons denote β—sheets, a—helices
and loop regions respectively in the secondary structure of the enzyme. The active site residues are shown in ball—andstick. The added sidechains and loop are colored green and red respectively.

•CI
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Fig. 11. Homology—based model of a charge—neutralized mutant Human Acetylcholinesterase with secondary structure features.
The mutated amino acid residues are colored purple. The amino acid residues of the enzyme's catalytic triad are also shown.
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mass of ACh from the Ca atom of Ser200 residue of the active site of Torpedo ACNE.

Figure 12. Relative total energy of the Torpedo AChE—ACh complex as a function of the distance of the center of
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Figure 13. Total relative energy of the Human AChE—ACh complex as a function of the distance of the center of
mass of ACh from the Ca atom of Ser234 residue of the active site of Human AChE.

Distance from Ca of Ser234 (Angs.)

0

Figure 14, Relative total energy of the mutated Human AChE—ACh complex as a function of the distance of the center
of mass of ACh from the Ca atom of the Ser234 residue of the active site of the mutated Human ACNE.

Distance from Ca of Ser234 (Angs.)
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Analog 1

Edrophonium

Sarin PS

Figure 15. Selected reversible and irreversible AChE inhibitors

Decamethonium

Sarin PR

DFP

105

A

Figure 16. Hydrogen bonding (A) and hydrophobic interactions (B) of the organophosphate
moiety of Sarin PR with surrounding amino acid residues of Torpedo AChE.
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A

B
Figure 17. Hydrogen bonding (A) and hydrophobic interactions (B) of the organophosphate
moiety of Sarin PS with surrounding amino acid residues of Torpedo AChE.
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A
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Figure 18. Hydrogen bonding (A) and hydrophobic interactions (B) of the organophosphate
moiety of Sarin PR with surrounding amino acid residues of Human

108

A

Figure 19. Hydrogen bonding (A) and hydrophobic interactions (B) of the organophosphate
moiety of Sarin PS with surrounding amino acid residues of Human AChE.
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B

Figure 20. Hydrogen bonding (A) and hydrophoblic interactions (B) of the organophosphate
moiety of DFP with surrounding amino acid residues of Torpedo Californica AChE.
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Figure 21. Hydrogen bonding (A) and hydrophobic interactions (B) of the organophosphate
moiety of DFP with surrounding amino acid residues of Human AChE.
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Figure 22. Relative total energy of the Torpedo AChE—Sarin PR complex as a function of the distance of the center of
mass of Sarin PR from the Ca atom of the Ser200 residue of the active site of Torpedo ACNE.

Distance from Ca of Ser200 (Angs.)

Figure 23. Relative total energy of the Torpedo AChE—Sarin PS complex as a function of the distance of the center of
mass of Sarin PS from the Ca atom of the Ser200 residue of the active site of Torpedo ACNE.
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Figure 24. Relative total ener gy of the Torpedo AChE—DFP complex as a function of the distance of the center of mass
of DFP from the Ca atom of the Ser200 residue of the active site of Torpedo ACNE.

Distance from Ca of Ser200 (Angs.)

Figure 25. Relative total energy of the Human AChE—Sarin PR complex as a function of the distance of the center of
mass of Sarin PR from the Ca atom of the Ser234 residue of the active site of Human ACNE.

Distance from Ca of Ser234 (Angs.)

Figure 26. Relative total energy of the Human AChE—Sarin PS complex as a function of the distance of the center of
mass of Sarin PS from the Ca atom of the Ser234 residue of the active site of Human ACNE

Distance from Ca of Ser234 (Angs.)

Figure 27. Relative total energy of the Human AChE—DFP complex as a function of the distance of the center of mass
of DFP from the Ca atom of Ser234 residue of the active site of Human ACNE.

Distance from Ca of Ser234 (Angs.)
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Figure 28. Superposition of the eleven identified docking conformations of Analog 1 within the active site gorge of
Human AChE.

Pattern F

Pattern H

Figure 29. Superposition of the thirteen identified docking conformations of Analog 2 within the active site gorge of Human ACNE.
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Figure 30. Superposition of the eleven identified docking conformations of Analog 3 within the active site gorge of Human AChE

Figure 31. Predicted lowest energy binding conformations of Analog 1 in Human Acetylcholinesterase.
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PATTERN K

Figure 32. Predicted lowest energy binding conformations of Analog 2 in Human Acetylcholinesterase.
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PATTERN D

Figure 33. Predicted lowest energy binding conformations of Analog 3 in Human Acetylcholinesterase.

PATTERN E
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